Lytic polysaccharide monooxygenases (LPMOs) are a new class of metalloenzymes discovered in the last decade. LPMOs are now thought to be key enzymes in the biological and biotechnological degradation of biomass and are reviewed here from a structural biology viewpoint.
Keywords: lytic polysaccharide monooxygenases, carbohydrate-modifying enzymes, metalloproteins, copper enzymes, biomass degradation
Abstract
Lytic polysaccharide monooxygenases (LPMOs) are a new class of microbial copper enzymes involved in the degradation of recalcitrant polysaccharides. They have only been discovered and characterized in the last 5–10 years and have stimulated strong interest both in biotechnology and in bioinorganic chemistry. In biotechnology, the hope is that these enzymes will finally help to make enzymatic biomass conversion, especially of lignocellulosic plant waste, economically attractive. Here, the role of LPMOs is likely to be in attacking bonds that are not accessible to other enzymes. LPMOs have attracted enormous interest since their discovery. The emphasis in this review is on the past and present contribution of crystallographic studies as a guide to functional understanding, with a final look towards the future.
1. Discovery of LMPOs and initial structural and functional studies
1.1. Setting the scene: enzymes breaking glycosidic linkages
Enzymes that are able to break glycosidic linkages (which we refer to here generically as glycosidases) have been of great interest to scientists for about a century. Alexander Fleming discovered the antibacterial properties of mucus lysozyme (Fleming, 1922 ▸) in his quest for antibiotics. Lysozyme acts as an antibacterial by cleaving the glycosidic linkage in bacterial peptidoglycans and has since become one of the most important models in protein chemistry. The hen egg-white variant was the first enzyme for which a high-resolution structure was determined, by David C. Phillips in the 1960s (Blake et al., 1965 ▸), paving the way for the understanding of enzyme mechanisms at the atomic level. Influenza neuraminidase is another example of a glycosidase which is essential for the release of virus particles from infected cells, and has been a major structure-based drug-design target (von Itzstein & Thomson, 2009 ▸). Lysozyme and neuraminidase have in common a hydrolytic mechanism for breaking the glycosidic linkage, which they share with most known glycosidases and for which examples are shown in Figs. 1 ▸(a) and 1 ▸(b). An alternative mechanism for breaking the glycosidic linkage introduces a carbon–carbon double bond in the product and is used by, for example, the plant pathogen virulence factors known as pectate lyases (Yoder et al., 1993 ▸; Fig. 1 ▸ c).
Glycoactive enzymes have also attracted great interest for the exploitation of biomass. Biomass from land plants (Bornscheuer et al., 2014 ▸), algae (Wei et al., 2013 ▸), insects and crustacean shells (Hayes et al., 2008 ▸) is rich in polysaccharides. Instead of accumulating in landfills or being burnt, waste biomass could be exploited for the production of bioethanol or value-added products such as biodegradable plastics, sweeteners, pharmaceuticals etc. (Bayer et al., 2007 ▸; Bornscheuer et al., 2014 ▸; Vaaje-Kolstad et al., 2013 ▸). However, depolymerization of the polysaccharides into fermentable sugars or simpler building blocks is necessary for most applications, but is hindered by crystallinity and the complex matrix in which the polysaccharides are embedded (Carpita & Gibeaut, 1993 ▸; Zeng et al., 2014 ▸). Consequently, considerable efforts have been made in the study of microbial cellulose, hemicelluloses and chitin-degrading enzymes. A classification system for cellulases/xylanases (Henrissat et al., 1989 ▸) was in fact one of the predecessors of the the CAZy (Carbohydrate Active enZYmes) database (Henrissat, 1991 ▸; Lombard et al., 2014 ▸), which is arguably the most useful bioinformatics resource in glycobiology. The CAZy database is sequence- and structure-based, and thus can easily incorporate genomic data, yet tries to make the connection to function wherever possible. CAZy currently classifies glycoside hydrolases into GH families 1–135, and many more carbohydrate-active enzymes into other families.
1.2. The early history of LPMO discovery
The first two families of LPMOs to be discovered were a fungal and mainly cellulolytic family and a mainly bacterial and chitinolyic family. The somewhat independent early histories of these two families, which eventually converged in 2010, are summarized here, but are outlined in more detail in at least two previous reviews (Lo Leggio et al., 2012 ▸; Vaaje-Kolstad, Horn et al., 2005 ▸). CBP21 (chitin-binding protein 21) was the first LPMO to be characterized in detail as part of the chitinolytic system of the bacterium Serratia marcescens (Vaaje-Kolstad et al., 2013 ▸). Identified in 1986 (Fuchs et al., 1986 ▸), it was first thought to have the main function of chitin binding (Suzuki et al., 1998 ▸), and as such was classified into a family of carbohydrate-binding modules (CBMs; Boraston et al., 2004 ▸) in the CAZy database (CBM33). The structure was determined in 2005 (Vaaje-Kolstad, Houston et al., 2005 ▸; see below) and on first inspection seemed consistent with the proposed chitin-binding role. In the same year, it was established that CBP21 acted synergistically with chitin-active glycoside hydrolases to boost chitin degradation (Vaaje-Kolstad et al., 2013 ▸). The oxidoreductase activity was first discovered in 2010 (Vaaje-Kolstad et al., 2010 ▸), finally assigning the proper enzymatic role to CBP21 and other proteins belonging to CBM33.
In parallel to the discovery of these bacterial chitinolytic LPMOs, a fungal family of cellulolytic enzymes, initially classified as glycoside hydrolases in GH61, was puzzling researchers in the field. The family was reported in the literature in 1997 (Henrissat & Davies, 1997 ▸) and had just four members in 2001 (Karlsson et al., 2001 ▸). Despite strong implication in cellulose degradation, demonstration of cellulolytic activity was problematic, as reviewed in Lo Leggio et al. (2012 ▸). In 2006 a patent indicated that GH61 could act synergistically to boost conventional cellulolytic hydrolases (Brown et al., 2006 ▸). The first structures (see §2.1 for further details; Karkehabadi et al., 2008 ▸; Welner et al., 2009 ▸; Harris et al., 2010 ▸) firmly established the structural similarity to CBP21, and furthermore revealed the presence of divalent metal ions at a structurally conserved site (see §2.2), which had not been clear in the first CBP21 structure. In 2010, the same year as in which enzymatic activity of CBP21 was demonstrated, additional evidence of the synergy between GH61 and cellulose-degrading glycoside hydrolases was presented, together with structure-based mutagenesis of the metal site which linked it to activity (Harris et al., 2010 ▸). Thus, 2010 really marks the beginning of the systematic study of LPMOs as major factors in the degradation of recalcitrant polysaccharides, although oxidative action was first demonstrated for GH61 in 2011 (Quinlan et al., 2011 ▸; Phillips et al., 2011 ▸; Westereng et al., 2011 ▸; Langston et al., 2011 ▸).
LPMOs introduce a single O atom from molecular oxygen into the product, and utilize an external electron donor, for example ascorbate, in the process (Fig. 1 ▸ d; Vaaje-Kolstad et al., 2010 ▸). It is remarkable that although the importance of redox chemistry in the degradation of cellulose has been recognized since at least the 1970s (Eriksson et al., 1974 ▸), LPMO activity was first proved 40 years later, revolutionizing our previous view of cellulose and biomass degradation in nature (Béguin, 1990 ▸). It must be emphasized that the involvement of redox enzymes in biomass degradation, in itself, is not novel. Lignin degradation in particular, although as yet rather poorly characterized, is known to rely heavily on redox enzymes such as peroxidases and laccases (Guerriero et al., 2016 ▸; Cragg et al., 2015 ▸; Pollegioni et al., 2015 ▸). Carbohydrate oxidases that oxidize monosaccharides, disaccharides and oligosaccharides (van Hellemond et al., 2006 ▸), but without leading to chain cleavage, have also been known for a number of years, and their biological functions are varied and often still rather unclear, although lignocellulose degradation is also one of them. Lignin-degrading enzymes are not always very specific for their substrate, and often generate reactive species that can dissociate from the enzyme active site and act distally on a number of substrates, while some of the carbohydrate oxidases that have long been implicated in lignocellulose degradation act in indirect ways, for example by producing peroxide equivalents for other lignin-degrading enzymes. What is truly novel for LPMOs as redox enzymes in biomass degradation is their implication in the direct and specific depolymerization of polysaccharides, a biological function that was previously thought to be almost exclusively performed by hydrolases. This discovery has had far-reaching consequences for biotechnological applications and our understanding of the carbon cycle in nature (see also §1.3).
These discoveries prompted the reclassification of LPMOs in CAZy as auxiliary activities (AAs), together with other redox enzymes acting on lignin/lignocellulose, including many carbohydrate oxidases (Levasseur et al., 2013 ▸). GH61 was renamed AA9, CBM33 was renamed AA10 and two additional LPMO families since identified have been named AA11 and AA13 (Hemsworth et al., 2014 ▸; Vu, Beeson, Span et al., 2014 ▸). From now on in this review we will indicate individual LPMOs by the initials of the Latin name of the organism in italics followed by the AA family and if necessary a further specifier, e.g. TaAA9_A and SmAA10_A (CBP21). Based on sequence, AA9 was further divided into groups suggested to reflect the site of oxidation. Thus, AA9 is subdivided into type 1 (C1-oxidizing), type 2 (C4-oxidizing) or type 3 (more promiscuous, generally C1- and C4-oxidizing, with the exception of PMO-3* which only oxidizes C1) (Vu, Beeson, Phillips et al., 2014 ▸; Li et al., 2012 ▸; Phillips et al., 2011 ▸), but there is some controversy as to whether the oxidation site strictly follows a phylogenetic relationship. Other subdivisions of AA9 and other AA families based on sequence have been suggested, for example, by Busk & Lange (2015 ▸) and Book et al. (2014 ▸).
The importance of structural studies in the early stages of LPMO discovery cannot be overestimated, as they were instrumental in establishing that AA9 and AA10 were functionally linked and that their action, enzymatic or otherwise, was dependent on the presence of a metal. In the case of LPMOs structural knowledge really can claim to have driven functional understanding.
1.3. LPMOs: why all the fuss?
As outlined above, LPMOs are, in a nutshell, a newly discovered class of oxidative copper enzymes that degrade polysaccharides, a previously unknown function for redox enzymes involved in biomass degradation. Since their discovery the literature regarding LPMOs has really taken off. A search for ‘polysaccharide monooxygenase’, ‘CBM33’, ‘GH61’, ‘CBP21’ and related terms in Web of Science (excluding patents) returned one relevant result in 2000, two in 2005, two in 2010 and 43 in 2015, with no sign of diminishing interest in 2016.
Before embarking on a detailed view of their structures, we would like to highlight a few of the reasons why these LPMOs have created such a stir. In addition to their potential in biomass degradation, which is perhaps the aspect that has attracted the most attention (Horn et al., 2012 ▸; Harris et al., 2014 ▸; Johansen, 2016a ▸), a medical dimension may well reveal itself to be very important in the future, since a number of bacterial chitinolytic systems have been implicated in virulence and pathogenicity (Frederiksen et al., 2013 ▸). Vibrio cholerae, Listeria monocytogenes and Enterococcus faecalis, all of which are human pathogens, possess chitinolytic systems including an active AA10 LPMO (Loose et al., 2014 ▸; Paspaliari et al., 2015 ▸; Vaaje-Kolstad et al., 2012 ▸).
LPMOs may have profound environmental impact in nature owing to their effect in the global carbon cycle (C cycle). Fungal species play a significant role in the turnover of terrestrial C pools and thus in the global C cycle (Glass et al., 2013 ▸; Rytioja et al., 2014 ▸; Floudas et al., 2015 ▸). Fungi are often divided into either saprotrophs (degrading dead organic matter) or biotrophs with a symbiotic lifestyle with a plant host (mutualistic or parasitic). Saprotrophic filamentous fungi have a variety of plant cell wall-degrading enzymes, and are important for the turnover of carbon as they deconstruct lignocellulosic biomass. LPMO-encoding genes are highly abundant in these organisms and LPMOs are predicted to play a significant role in global carbon flux. In many symbiotic biotrophic fungi (known as mycorrhizal fungi) the number of genes encoding plant cell wall-degrading enzymes is greatly reduced (Kohler et al., 2015 ▸; Shah et al., 2016 ▸). However, several genes encoding lignocellulosic degrading oxidative enzymes are retained, of which a substantial part are LPMOs, indicating that they are also advantageous to biotrophic fungi, and thus expanding the importance of LPMOs in the natural C cycle. The abundance of LPMOs in nature has additional environmental consequences that are of interest to human life. AA9 LPMOs are well represented in plant fungal pathogens, where they may be factors in pathogenesis (Gibson et al., 2011 ▸), and in fungi causing wood decay, especially white-rot fungi (Floudas et al., 2012 ▸). Recently, fusolin, the protein that forms the spindles of insect poxviruses, which have potential in pest control, was found to consist of an AA10 LPMO (Chiu et al., 2015 ▸).
The bioinorganic chemistry of LPMOs is also unusual and has attracted considerable attention: they have a type 2 copper site (Crichton, 2012 ▸), which will be reviewed in more detail in §2.2, but with only two histidines, whereas other enzymes have three or four. Furthermore, it is intriguing how a mononuclear copper site can achieve a two-electron reaction, which is one of the most supported current mechanistic hypotheses, and how it can break the extremely strong C—H bond (Walton & Davies, 2016 ▸).
Given the level of interest in LPMOs, a number of reviews have been written focusing solely or largely on these enzymes. Among the slightly older but still influential reviews are one focused on bioethanol production (Horn et al., 2012 ▸) and one on early structural studies (Hemsworth, Davies et al., 2013 ▸). Most recent reviews have covered specific aspects such as the important role of LPMOs in lignocellulose degradation across the tree of life (Cragg et al., 2015 ▸), their biotechnological potential (Hemsworth et al., 2015 ▸), their mechanism (Walton & Davies, 2016 ▸), their industrial applications (Johansen, 2016a ▸) and their role in plant–microbe interactions (Johansen, 2016b ▸). Recently, a brief structural and functional overview of all LPMO families has also been published (Span & Marletta, 2015 ▸), as well as two more specific and detailed reviews on cellulose-degrading LPMOs (Beeson et al., 2015 ▸) and starch-degrading LPMOs (Vu & Marletta, 2016 ▸). The present review attempts to be somewhat different from previous reviews, being written as it were by crystallographers with crystallographers and other structural biologists as an audience, and not necessarily experts on LPMOs or carbohydrate-modifying enzymes. Furthermore, as the field moves extremely rapidly, we also hope to provide a useful update and overview for LPMO aficionados.
2. Structure-driven discovery of function
2.1. First structures: the early years 2008–2010
It would be unfair to say that only structural knowledge has provided clues to the function of this class of proteins, but it has definitely played an enormous role. SmAA10_A was the first LPMO for which a structure was determined (Vaaje-Kolstad, Houston et al., 2005 ▸; please refer to Table 1 ▸ for the PDB codes and details of all structures that are mentioned). The structure of SmAA10_A revealed a β-sandwich fold, described as a ‘budded’ fibronectin type III fold, where the bud consists of a 65-residue, predominantly helical insert between β-strands 1 and 2. The β-sandwich itself is rather unremarkable; a recent search of the Protein Data Bank (PDB) with DALI (Holm et al., 2008 ▸) found PDB entry 2p9r (the MG2 domain of human α2-macroglobulin; Doan & Gettins, 2007 ▸) as the closest non-LPMO hit, and the backbone fit is remarkable (Figs. 2 ▸ a and 2 ▸ c) despite the absence of an obvious functional relationship. Surprisingly, the conserved aromatic residues that had been proposed to play a role in substrate binding prior to structure determination were instead found to form the hydrophobic core. The structure was key in identifying a patch of conserved and in part hydrophilic residues, and the role of most of these residues in substrate binding (especially Tyr45 and Glu60) was confirmed by mutagenesis. At this point, however, there was no suspicion that this could be a metalloenzyme and no metal site was identified.
Table 1. X-ray crystal structures of LPMOs.
Crystallization and diffraction data | Active site | Specificity | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Family | Organism | Protein name | PDB code | ASU† | Protein concentration and buffer | Crystallization conditions | Space group | Res. (Å) | Element (oxidation)‡ | Residues | Substrates | Site of attack | Comments | Reference |
AA9 | Lentinus similis | LsAA9_A | 5acf | 1 | 19.2 mg ml−1, 0.02 M sodium acetate pH 5.5 | 3.6 M NaCl, 0.1 M citric acid pH 4.0 (pH 5.5) | P4132 | 1.80 | Copper(II) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 mM copper(II) acetate. Cellotriose bound in the active site. Exogenous ligand (Cl−) mimicking superoxide. | Frandsen et al. (2016 ▸) |
AA9 | Lentinus similis | LsAA9_A | 5acg | 1 | 19.2 mg ml−1, 0.02 M sodium acetate pH 5.5 | 3.9 M NaCl, 0.1 M citric acid pH 4.0 (pH 5.5) | P4132 | 1.91 | Copper(II) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 mM copper(II) acetate. | Frandsen et al. (2016 ▸) |
AA9 | Lentinus similis | LsAA9_A | 5ach | 1 | 8.5 mg ml−1, 0.02 M sodium acetate pH 5.5 | 3.0 M NaCl, 0.1 M citric acid pH 3.5 (pH 5.5) | P4132 | 1.28 | Copper(II)/copper(I) 0.9 | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 mM copper(II) acetate. | Frandsen et al. (2016 ▸) |
AA9 | Lentinus similis | LsAA9_A | 5aci | 1 | 19.2 mg ml−1, 0.02 M sodium acetate pH 5.5 | 3.6 M NaCl, 0.1 M citric acid pH 4.0 (pH 5.5) | P4132 | 1.75 | Copper(II)/copper(I) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 mM copper(II) acetate. Cellohexaose bound in the active site. | Frandsen et al. (2016 ▸) |
AA9 | Lentinus similis | LsAA9_A | 5acj | 1 | 19.2 mg ml−1, 0.02 M sodium acetate pH 5.5 | 3.0 M NaCl, 0.1 M citric acid pH 3.5 (pH 5.5) | P4132 | 1.70 | Copper(I) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 mM copper(II) acetate. Cellotriose bound in the active site. | Frandsen et al. (2016 ▸) |
AA9 | Neurospora crassa | NcAA9_D, NcLPMO9D, PMO-2, NCU01050, GH61-4 | 4eir | 2 | 0.15 M NaCl, 0.010 M Tris pH 8.5 | PEG 3350 (pH 6.7) | P21 | 1.10 | Copper(II)/copper(I) | MeHis1, His84, Tyr168 | PASC | C4 | Proposed O2 molecule near active-site axial position. | Li et al. (2012 ▸), Phillips et al. (2011 ▸) |
AA9 | Neurospora crassa | NcAA9_F, NcLPMO9F, PMO-03328, NCU03328, GH61-6 | 4qi8 | 2 | — | 0.2 M NH4NO3, 20%(w/v) PEG 3350 pH 7.0 | P21212 | 1.10 | Copper(II) | His1, His72, Tyr157 | PASC | C1 | Regiospecificity in Vu, Beeson, Phillips et al. (2014 ▸). | Tan et al. (2015 ▸), Phillips et al. (2011 ▸) |
AA9 | Neurospora crassa | NcAA9_M, NcLPMO9M, NcPMO-3, PMO-3, NCU07898, GH61-13 | 4eis | 2 | 104 mg ml−1, 0.010 M Tris pH 8.5 | 0.1 M NaCl, 0.010 M Tris pH 8.5 | P21 | 1.37 | Copper(I) | MeHis1, His82, Tyr171 | PASC | C1/C4 | Proposed peroxide ion near active site. Tyr24 oxidation. | Li et al. (2012 ▸), Phillips et al. (2011 ▸) |
AA9 | Neurospora crassa | NcAA9_C, NcLPMO9C, NCU02916, PMO-02916, GH61-3 | 4d7u | 2 | 1.4 mg ml−1 | 0.2 M NH4 citrate, 20%(w/v) PEG 3350 pH 5.1 | P21 | 1.56 | Copper(I) | His1, His83, Tyr166 | PASC, cellooligosaccharides, xyloglucan, glucomannan, β-glucan | C4 | — | Borisova et al. (2015 ▸) |
AA9 | Neurospora crassa | NcAA9_C, NcLPMO9C, NCU02916, PMO-02916, GH61-3 | 4d7v | 2 | 1.4 mg ml−1 | 0.2 M zinc(II) acetate, 17.5/20.0%(w/v) PEG 3350 pH 8.0 | P21 | 1.90 | Zinc(II) | His1, His83, Tyr166 | PASC, cellooligosaccharides, xyloglucan, glucomannan, β-glucan | C4 | — | Borisova et al. (2015 ▸) |
AA9 | Phanerochaete chrysosporium | PcAA9_D, PcLPMO9D, PcGH61D, GH61D | 4b5q | 2 | 12 mg ml−1, 0.01 M sodium acetate pH 5.0 | 2.1 M malic acid (racemic) pH 7.0 | C2 | 1.75 | Copper(I) | His1, His76, Tyr160 | PASC, Avicel | C1 | — | Wu et al. (2013 ▸) |
AA9 | Thermoascus aurantiacus | TaAA9_A, TaAA9A, TaGH61, TaGH61A, TaLPMO9A | 3zud | 1 | 15 mg ml−1, 0.02 M sodium acetate pH 5.5 | 0.2 M NaCl, 0.1 M HEPES pH 7.5, 25%(w/v) PEG 3350 | P21 | 1.25 | Copper(II)/copper(I); A, 0.6; B, 0.15 | MeHis1, His86, Tyr175 | PASC, PCS | C1/C4 | Crystal soaked in 10 mM copper(II) nitrate. | Quinlan et al. (2011 ▸) |
AA9 | Thermoascus aurantiacus | TaAA9_A, TaAA9A, TaGH61, TaGH61A, TaLPMO9A | 2yet | 2 | 15 mg ml−1, 0.02 M sodium acetate pH 5.5 | 0.2 M NaCl, 0.1 M HEPES pH 8.0, 25%(w/v) PEG 3350 | P21 | 1.50 | Copper 0.2 | MeHis1, His86, Tyr175 | PASC, PCS | C1/C4 | Quinlan et al. (2011 ▸) | |
AA9 | Thielavia terrestris | TtAA9_E, TtGH61E, GH61E, 131562 | 3eii | 4 | 3.1 mg ml−1 (pH 7.6–5.0) | 1.6 M MgSO4, 0.1 M MES pH 6.5 | F23 | 2.25 | Zinc(II) | His1, His68, Tyr153 | PASC, Avicel | C1 | Crystal soaked in 1.8 M ZnSO4, cacodylate pH 6.5. Regiospecificity inferred from Cannella et al. (2016 ▸). | Harris et al. (2010 ▸) |
AA9 | Thielavia terrestris | TtAA9_E, TtGH61E, GH61E, 131562 | 3eja | 4 | 3.1 mg ml−1 (pH 7.6–5.0) | 1.6 M MgSO4, 0.1 M MES pH 6.5 | F23 | 1.90 | Magnesium(II) | His1, His68, Tyr153 | PASC, Avicel | C1 | — | Harris et al. (2010 ▸) |
AA9 | Trichoderma reesei | HjAA9_B, HjGH61B, GH61B, Cel61B, EG7, TrAA9_B | 2vtc | 2 | 2.2 mg ml−1, 0.02 M sodium phosphate pH 6.8 | 15–20%(w/v) PEG 2000, 0.1 M Tris pH 8.4, 0.010 M NiCl2 | P65 | 1.60 | Nickel(II) | His1, His89, Tyr176 | Cellulose | N/D | — | Karkehabadi et al. (2008 ▸) |
AA10 | Bacillus amyloliquefaciens | BaAA10_A, BaCBM33, ChbB, Rbam17540 | 2yow | 2 | 7.0 mg ml−1, 0.02 M sodium acetate pH 5.0, 0.25 M NaCl | 0.1 M MMT pH 4.0, 25%(w/v) PEG 1500 | P21212 | 1.80 | — | His28, His125, Phe196 | N/D | N/D | Likely to be active on chitin. | Hemsworth, Davies et al. (2013 ▸) |
AA10 | Bacillus amyloliquefaciens | BaAA10_A, BaCBM33, ChbB, Rbam17540 | 2yox | 2 | 7.0 mg ml−1, 0.02 M sodium acetate pH 5.0, 0.25 M NaCl | 0.1 M MMT pH 4.0, 25%(w/v) PEG 1500 | P21 | 1.90 | Copper(I) | His28, His125, Phe196 | N/D | N/D | 1 mM copper(II) nitrate added to sample. | Hemsworth, Davies et al. (2013 ▸) |
AA10 | Bacillus amyloliquefaciens | BaAA10_A, BaCBM33, ChbB, Rbam17540 | 2yoy | 2 | 7.0 mg ml−1, 0.02 M sodium acetate pH 5.0, 0.25 M NaCl | 0.1 M MMT pH 4.0, 25%(w/v) PEG 1500 | P21212 | 1.70 | Copper(I) | His28, His125, Phe196 | N/D | N/D | — | Hemsworth, Davies et al. (2013 ▸) |
AA10 | Burkholderia pseudomallei | BpAA10_A | 3uam | 6 | 21 mg ml−1 | 0.1 M bis-tris propane pH 6.77, 0.2 M NaNO3, 20.54%(w/v) PEG 3500 | P1 | 2.00 | — | His19, His122, Phe205 | N/D | N/D | Mentioned in Book et al. (2014 ▸). | To be published |
AA10 | Cellvibrio japonicus | CjAA10_A CjLPMO10A, CJA_2191, Cbp33A, Lpmo10A | 5fjq | 3 | 9 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M sodium acetate pH 5.2, 22%(w/v) PEG 4000 | C2 | 1.85 | Copper(I) [copper(II) in chain B] | His37, His136, Phe205 | α-Chitin, β-chitin | C1 | Copper(II)-saturated sample. | Forsberg et al. (2016 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4a02 | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 1.0 M K/Na tartrate, 0.1 M imidazole pH 8.0, 0.2 M NaCl | P32 | 0.95 | — | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | — | Vaaje-Kolstad et al. (2012 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4alc | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.49 | Copper(II) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4ale | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.48 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4alq | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.48 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4alr | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.49 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4als | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.47 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Enterococcus faecalis | EfAA10_A, EfCBM33A, EfaCBM33, EF0362 | 4alt | 1 | 25 mg ml−1, 0.02 M Tris pH 8.0 | 0.1 M HEPES pH 7.5, 20%(w/v) PEG 8000 | P21212 | 1.49 | Copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 mM CuSO4. | Gudmundsson (et al., 2014 ▸) |
AA10 | Jonesia denitrificans | JdAA10_A, JdLPMO10A, Jden_1381 | 5aa7 | 2 | 20 mg ml−1, 0.02 M Tris pH 8.0 | 1.9 M DL-malic acid pH 7 | P212121 | 1.55 | Copper(I) | His32, His109, Phe164 | α-Chitin, β-chitin | C1 | — | Mekasha et al. (2016 ▸) |
AA10 | Serratia marcescens | SmAA10_A, SmLPMO10A, CBP21, Cbp21, Cbp | 2bem | 3 | 20 mg ml−1, 0.05 M Tris pH 8.0 | 1.26 M (NH4)2SO4, 0.1 M HEPES pH 7.5 | P21212 | 1.55 | Na2+ | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | Chain A and B have no active-site metal. | Vaaje-Kolstad, Houston et al., 2005 ▸) |
AA10 | Serratia marcescens | SmAA10_A, SmLPMO10A, CBP21, Cbp21, Cbp | 2ben | 2 | 17.5 mg ml−1, 0.05 M Tris pH 8.0 | 20%(w/v) PEG 8000, 0.1 M CHAPS, 0.2 M NaCl | P3221 | 1.80 | — | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | Y54A mutant. | Vaaje-Kolstad, Houston et al. (2005 ▸) |
AA10 | Serratia marcescens | SmAA10_A, SmLPMO10A, CBP21, Cbp21, Cbp | 2lhs | — | 0.8–1.2 mM, 0.02 M K3PO4, 0.01 M NaCl | pH 5.5 | — | — | — | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | NMR structure. | Aachmann et al. (2012 ▸) |
AA10 | Streptomyces coelicolor | ScAA10_B, ScLPMO10B, SCO0643, SCF91.03c | 4oy6 | 1 | 10.3 mg ml−1, 0.02 M Tris pH 8.0 | 0.2 M zinc acetate, 0.1 M sodium cacodylate pH 6.5, 9%(v/v) 2-propanol | P3121 | 1.29 | Copper(II)/copper(I) 0.95 | His43, His150, Tyr219 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | Soaked in 1–20 mM CuCl2 (zinc acetate reduced to 0.1 M). | Forsberg, Mackenzie et al. (2014 ▸) |
AA10 | Streptomyces coelicolor | ScAA10_B, ScLPMO10B, SCO0643, SCF91.03c | 4oy8 | 1 | 10.3 mg ml−1, 0.02 M Tris pH 8.0 | 0.2 M zinc acetate, 0.1 M sodium cacodylate pH 6.5, 9%(v/v) 2-propanol | P3121 | 1.40 | Zinc(II) 0.8 | His43, His150, Tyr219 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | — | Forsberg, Mackenzie et al. (2014 ▸) |
AA10 | Streptomyces coelicolor | ScAA10_C, ScLPMO10C, LPMO10C, CelS2, SCO1188, SCG11A.19 | 4oy7 | 8 | 9.2 mg ml−1, 0.02 M Tris pH 8.0 | 9%(w/v) PEG 10 000, 0.1 M sodium citrate, 0.1 M calcium acetate, 5%(v/v) glycerol | P212121 | 1.50 | Copper(II)/copper(I) 0.5 | His35, His144, Phe219 | PASC, Avicel | C1 | — | Forsberg, Mackenzie et al. (2014 ▸) |
AA10 | Streptomyces lividans | SlAA10_E, SliLPMO10E, SLI_3182 | 5ftz | 1 | 15 mg ml−1, 0.01 M sodium acetate pH 5.0, 0.15 M NaCl | 0.1 M sodium acetate pH 4.6, 25%(w/v) PEG 4000 | C2 | 1.38 | Copper(I) 0.8 | His30, His120, Phe193 | β-Chitin | C1/(C4) | Definite C1 oxidation Indications of C4 oxidation. | Chaplin et al. (2016 ▸) |
AA10 | Thermobifida fusca | TfAA10_A, TfLPMO10A, E7, Tfu_1268 | 4gbo | 2 | — | 0.1 M HEPES pH 7.5, 4.3 M NaCl | P3221 | 2.00 | Copper(I) 0.5 | His37, His144, Tyr213 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | Regiospecificity in Forsberg, Mackenzie et al. (2014 ▸). | To be published |
AA10 | Vibrio cholerae | VcAA10_B, VCA0811, VcGbpA, GbpA | 2xwx | 2 | 2 mg ml−1, 0.02 M Tris pH 7.5 | 0.2 M Mg(HCO3)2, 50%(w/v) PEG 3350, 3.33%(w/v) D-sorbitol pH 7.5 | P21 | 1.80 | — | His24, His121, Phe193 | N/D | N/D | — | Wong et al. (2012 ▸) |
AA10 | Anomala cuprea entomopoxvirus | Fusolin (ACV034) | 4yn1 | 1 | — | In vivo crystallization (pH 7.0) | P41212 | 1.90 | — | His1, His142, Phe225 | N/D | N/D | Intracellular fusolin microcrystals from EPV-infected larvae of A. cuprea moths. | Chiu et al. (2015 ▸) |
AA10 | Unidentified entomopoxvirus | Fusolin (partial) | 4yn2 | 1 | — | In vivo crystallization (pH 7.0) | P41212 | 2.02 | Zinc(II) | His1, His222 | N/D | N/D | Intracellular fusolin microcrystals from EPV-infected larvae of Wiseana spp. moths. | Chiu et al. (2015 ▸) |
AA10 | Unidentified entomopoxvirus (Melolontha melolontha entomopoxvirus) | Fusolin | 4ow5 | 1 | — | In vivo crystallization | P41212 | 1.90 | (H2O) | His1, His142, Phe225 | N/D | N/D | Active-site water molecule may be a low-occupied metal ion. Chitin-binding domain. Mutations: G25D, H192N, I351N, I352H, Q353T, D354G. | Chiu et al. (2015 ▸) |
AA10 | Unidentified entomopoxvirus (Melolontha melolontha entomopoxvirus) | Fusolin | 4x27 | 1 | — | In vivo crystallization | P41212 | 2.40 | Copper(II) 0.79 | His1, His142, Phe225 | N/D | N/D | Soaked with CuSO4. | Chiu et al. (2015 ▸) |
AA10 | Unidentified entomopoxvirus (Melolontha melolontha entomopoxvirus) | Fusolin | 4x29 | 1 | — | In vivo crystallization | P41212 | 2.41 | Zinc(II) | His1, His142, Phe225 | N/D | N/D | Soaked with ZnSO4. | Chiu et al. (2015 ▸) |
AA11 | Aspergillus oryzae | AoAA11 Ao(LPMO11) (AO090102000501) | 4mah | 1 | 25 mg ml−1, 0.02 M sodium acetate pH 5.0 | 0.01 M ZnCl2, 0.1 M MES pH 6.0, 20%(w/v) PEG 6000 | P212121 | 1.55 | Zinc(II) | His1, His60, Tyr140 | β-Chitin | C1 | — | Hemsworth et al. (2014 ▸) |
AA11 | Aspergillus oryzae | AoAA11 Ao(LPMO11) (AO090102000501) | 4mai | 1 | 25 mg ml−1, 0.02 M sodium acetate pH 5.0 | 0.01 M ZnCl2, 0.1 M MES pH 6.0, 20%(w/v) PEG 6000 | P212121 | 1.40 | Copper(I) | His1, His60, Tyr140 | β-Chitin | C1 | Soaked in 2 mM CuCl2. | Hemsworth et al. (2014 ▸) |
AA13 | Aspergillus oryzae | AoAA13 (AO090701000246) (AOR_1_454114) | 4opb | 1 | 3 mg ml−1, 0.02 M MES pH 6.0, 0.125 M NaCl | 0.14 M CaCl2, 0.07 M sodium acetate pH 4.6, 14%(v/v) 2-propanol, 30%(v/v) glycerol (+ seed stock) | P212121 | 1.55 | Copper(I) | MeHis1, His91, Tyr224 | N/D (starch) | N/D (C1) | Enzymes with 70–72% sequence identity [AnAA13 in Lo Leggio et al. (2015 ▸) and NcAA13 in Vu, Beeson, Phillips et al. (2014 ▸)] release C1-oxidized products from starch-related substrates. | Lo Leggio et al. (2015 ▸) |
Number of molecules in the asymmetric unit.
The criteria for assigning a copper(II) or copper(I) state were informed by structures where both states have been characterized (Gudmundsson et al., 2014 ▸). The electron density of the equatorial exogenous ligand to the copper (from weighted 2F obs − F calc) should be more than 2σ with more than 0.5 occupancy and a distance to the copper of less than 2.4 Å, with similar criteria applying to the exogenous axial ligand, although with a distance of 2.8 Å. In structures where a distorted geometry is observed because of significant steric effects (most AA10 members), structures with a single exogenous ligand within 2.5 Å distance are taken as copper(II). The occupancy of the metal is 1.00 if no other value is indicated. If there is significant metal-site disorder with characteristics that could fit both states, the site is described as copper(II)/copper(I). When the copper occupancy was lower than 0.5, no oxidation state was assigned.
When the first structures of fungal LPMOs in the AA9 family were determined, the most important discovery was perhaps their similarity to the structure of SmAA10_A (Karkehabadi et al., 2008 ▸; Welner et al., 2009 ▸; Harris et al., 2010 ▸), forming a definite connection between GH61 and CBM33 (now AA9 and AA10). Furthermore, the structures revealed unusual features for glycoside hydrolases; for example, the lack of a conserved carboxylate pair and a clear active-site cleft or groove. However, TtAA9_E showed an arrangement of aromatic residues that was strongly reminiscent of a family 1 CBM, a type A CBM (meaning that it is specific for crystalline polysaccharides; Boraston et al., 2004 ▸), and suggesting that these proteins acted by binding to crystalline cellulose.
Importantly, the structures also revealed a metal-binding site on the same face as these aromatic residues. This site was occupied by a nickel ion from the crystallization conditions (see Table 1 ▸) in the structure of Trichoderma reesei AA9_B (TrAA9_B), which was actually determined by SAD using the nickel anomalous signal from data collected at a wavelength of 1.485 Å. The structure of TtAA9_E, which shares only 29% sequence identity with TrAA9_B and was determined by MIR (Welner et al., 2009 ▸; Harris et al., 2010 ▸), shows a similar metal-binding site. In the two deposited structures of TtAA9_E the metal is modelled as an Mg or a Zn ion, depending on the crystallization/soaking conditions (Table 1 ▸). In retrospect, it is most likely that the metal visible in the ‘Mg’ complex is in fact a poorly occupied Cu ion; indeed, the CheckMyMetal server (Zheng et al., 2014 ▸), which was unfortunately not yet available at the time, flags one of the ‘Mg’ sites as a possible copper-binding site. Arguably the major finding by Harris et al. (2010 ▸), comes from connecting the identified structural features to function by structure-guided mutagenesis of the relevant residues. Despite the limitations of the assay, which measured the boosting of conventional hydrolase activity, but without controlled inclusion of an electron donor or the correct metal, the studies demonstrated that the two His residues liganding the metal (one also through the N-terminus) were essential for activity, while a neighbouring Tyr and a conserved Gln which holds it in position by hydrogen bonding were almost essential. All of these residues are very highly conserved in AA9 sequences, as had already been noted by Karkehabadi et al. (2008 ▸). Furthermore, one of the Tyr residues in the putative cellulose-binding site was also important for activity.
2.2. The metal site
As highlighted above, while the first structures from the AA9 family and the mutagenesis thereof led to the understanding that a divalent metal-binding site was crucial for activity, the nature of this metal was not clear. At the time when oxidative cleavage was demonstrated for AA10 there was still debate as to the nature of the active metal. In 2011 a number of publications on AA9 LPMOs firmly demonstrated that the active metal was copper using a variety of methods including metal identification in isolated native protein activity assays, binding studies and structural/spectroscopic studies (Westereng et al., 2011 ▸; Phillips et al., 2011 ▸; Quinlan et al., 2011 ▸). Shortly afterwards, activity studies showed that copper was also the active metal in AA10 LPMOs (Vaaje-Kolstad et al., 2012 ▸). The identification of copper as the active-site metal ion was corroborated by structure determination of the first copper-loaded LPMO, TaAA9_A (Quinlan et al., 2011 ▸), demonstrating that catalysis is mediated by a deceivingly simple-looking metal centre: a copper ion coordinated by a motif christened the ‘histidine brace’ (His brace hereafter; Fig. 3 ▸). The K d for Cu2+ was estimated by ITC to be less than 1 nM, while at pH 5 no binding was observed with Mg2+, Ca2+, Mn2+, Co2+, Ni2+ or Zn2+.
Two structures of TaAA9_A were determined: one of the protein as purified, in which a low-occupancy copper was modelled, and one in the presence of a high concentration of copper (Table 1 ▸), showing disorder which was modelled as copper in a main conformation and an alternative (lower occupancy) conformation. Copper sites are classified into several types (Crichton, 2012 ▸), and type 2 sites are mononuclear and are often coordinated by multiple histidines (three or four) in a square-planar or tetragonal geometry. Type 2 copper sites additionally have a very characteristic EPR signature. Apart from the number of His residues that are involved, the structure and EPR spectroscopy of TaAA9_A were typical of a type 2 copper site with Jahn–Teller distorted octahedral geometry (elongation of the distance to the axial ligands) consistent with an at least partial copper(II) state, but with some disorder both of the copper and its exogenous ligands. Despite its limitations, this first structure of a Cu-loaded LPMO was very significant. For example, it was used to build active-site models for AA9, which could then be subjected to density functional theory calculations in order to investigate various aspects of the mechanism (Kim et al., 2014 ▸; Kjaergaard et al., 2014 ▸), in one case with additional experimental information derived from XANES and EXAFS in solution (Kjaergaard et al., 2014 ▸).
The first studies of the metal centre of an AA10 enzyme were performed on SmAA10_A. HSQC NMR spectra showed the binding of several metals at the His brace with decreasing K d values for Ca2+ (greater than 10 mM) > Mg2+ > Fe3+ > Co2+ >> Zn2+ > Cu2+. The K d values for Zn2+ and Cu2+ were determined by ITC as 330 and 55 nM, respectively. The K d for Cu+ was estimated indirectly as 1.2 nM (Aachmann et al., 2012 ▸). The article reporting the first X-ray structure of a copper-loaded AA10 from Bacillus amyloliquefaciens (Hemsworth, Taylor et al., 2013 ▸) also measured the affinity for Cu2+ to be 6 nM at pH 5 by ITC, with Zn2+ being the only other tested divalent metal ion with measurable binding. Binding of metals was also indicated by an increase in T m by 20 K for Cu2+ and 7 K for Ni2+ and Zn2+. There is thus a strong preference for copper, but some LPMOs are able to bind other ions (primarily zinc and nickel), in agreement with some of the ions bound in the early structures of AA9 members.
In BaAA10_A the metal is photoreduced and shows a T-shaped coordination geometry in the structure, being coordinated solely by the His brace. EPR in solution showed a mononuclear copper(II) ion in a single binding site with a distorted axial coordination geometry with characteristics that were between type 1 and type 2, but closer to type 2 according to the authors. Since AA9 structures with geometry compatible with copper(II) were available at the time, Hemsworth, Taylor et al. (2013 ▸) suggested that photoreduction is easier for members of the AA10 family than the AA9 family, probably reflecting mechanistic differences.
Clearly, photoreduction of the active-site copper(II) to copper(I) is a challenge in LPMO structural research. While one can argue that the copper(I) photoreduced state is catalytically relevant, the catalytically relevant oxygen-bound species are predominantly expected to be copper(II) species (see below), and it is likely that many of the structures of LPMOs deposited in the PDB represent mixture of states to some extent, complicating structural interpretation. In Table 1 ▸ we give the presumed predominant oxidation state in all determined crystal structures of LPMOs, our criteria (in the footnote to Table 1 ▸) being somewhat stricter than those of Gudmundsson et al. (2014 ▸). Copper-loaded structures are available for all four families of LPMOs known to date, but copper(II) structures are only available for a few representatives and not at all for AA11 and AA13. A careful study was carried out for Enterococcus faecalis AA10_A, which not only succeeded in obtaining the first structure of an AA10 in a predominantly copper(II) state by reducing the dose and by helical data collection, but also elegantly showed the evolution of photoreduction with a series of six structures collected from the same crystal with increasing X-ray dose (Gudmundsson et al., 2014 ▸). The structure of the copper(II) binding site is described as trigonal bipyramidal, although with significant distortion of the bonding angles (Fig. 3 ▸ a). As noted already in Hemsworth, Taylor et al. (2013 ▸), the exogenous ligands of the copper ion cannot have the same geometry in AA10 as in AA9 because of the steric constraints of a conserved Ala (shown also in Figs. 3 ▸ a and 3 ▸ b). The least and most photoreduced structures (Figs. 3 ▸ a and 3 ▸ b) of the active-site copper were subjected to quantum-mechanical calculations (Gudmundsson et al., 2014 ▸) and resulted in charges for the copper ion of +1.48 and +0.99, respectively, for the copper(II) and copper(I) forms, which is in excellent agreement with the results obtained by similar methods for TaAA9_A by Kim et al. (2014 ▸), where the derived charges on the copper(II) and copper(I) states are +1.48 and +0.92, respectively. Recently low X-ray dose structures showing predominantly copper(II) with very little disorder have also been reported for Lentinus similis AA9_A (LsAA9_A), which is shown for reference (Figs. 3 ▸ c and 3 ▸ d; Frandsen et al., 2016 ▸).
Structure determination of many LPMOs in AA9, AA10 and the newer families AA11 (chitin-acting) and AA13 (starch-acting) with bound copper have shown a remarkable conservation of the basic copper-binding motif regardless of specificity. The His brace forming the metal-binding site and its arrangement are extremely similar in all determined LPMO structures (Fig. 3 ▸ e). With regard to the aromatic residue at the metal-binding site, all AA9, AA11 and AA13 enzymes which have been structurally characterized have a Tyr residue, with the hydroxyl being at a borderline distance for coordination to copper. Most AA10 family members have, like SmAA10_A (Vaaje-Kolstad, Houston et al., 2005 ▸), a Phe instead of a Tyr (90% conservation), and an Ala preceding the second active-site His (Hemsworth, Taylor et al., 2013 ▸), a combination which prevents an identical coordination geometry of exogenous ligands to that in AA9. In AA9 and AA13, a conserved Gln residue two residues before in the sequence hydrogen bonds to the active-site Tyr (shown in Figs. 3 ▸ c and 3 ▸ d), while in AA11 the corresponding Glu fulfils the same role, indicating the importance of the Tyr in the active site of these families. The corresponding residue to Gln varies both in identity and in conformation in AA10, which is indicative of a less strict functional role. AA9 structures additionally have a conserved His that hydrogen bonds to the Gln. Interestingly, ScAA10_B, which is active on cellulose, and TfAA10_A (also known as E7; PDB entry 4gbo; P. M. Alahuhta & V. V. Lunin, unpublished work) have a Tyr instead of a Phe and preserve the hydrogen-bonding network to the active-site Tyr (both Gln and His), as well as having a type 2 Cu EPR spectrum similar to that reported for TaAA9_A (Forsberg, Mackenzie et al., 2014 ▸). Just as mutagenesis of Tyr to Phe in TtAA9_E impaired activity, mutation of Phe to Tyr in chitin-active AA10 enzymes impairs activity (Forsberg, Røhr et al., 2014 ▸).
A very recent publication suggested that AA10 is heterogenous in its copper binding, even though only one active-site copper(II) conformation was observed by X-ray crystallography (Chaplin et al., 2016 ▸). However, EPR spectra are best simulated with two similarly abundant solution species, one of which only coordinates to two side-chain N ligands (Chaplin et al., 2016 ▸). To our knowledge, the only crystallographic observation of an LPMO copper coordinated by two ligands to date is the minor conformation in the disordered copper at the active site of TaAA9_A, which is too distant (3.6 Å) from the N-terminus for coordination (Quinlan et al., 2011 ▸).
Most structures of characterized fungal LPMOs show an unusual post-translational modification: methylation at N∊1 of the N-terminal histidine (see, for example, Quinlan et al., 2011 ▸; Hemsworth et al., 2014 ▸; Lo Leggio et al., 2015 ▸). The role of this modification is currently unclear, but at least three AA9 members which have been expressed in Pichia pastoris and one AA11 expressed in Escherichia coli do not have this modification, and show activity nonetheless (Bennati-Granier et al., 2015 ▸; Westereng et al., 2011 ▸; Borisova et al., 2015 ▸; Hemsworth et al., 2014 ▸).
3. Substrate binding and catalysis
3.1. Initial identification of a substrate-binding surface
In order to fully understand and describe the mode of action of LPMO enzymes, thorough characterization of their protein–substrate interactions and specificity are needed. As described above, the first structure of an AA10, SmAA10_A, revealed a conserved patch of hydrophilic residues that were proven to be involved in substrate binding by mutagenesis (Vaaje-Kolstad, Houston et al., 2005 ▸). The SmAA10_A–chitin interaction at this surface was later mapped by NMR spectroscopy by monitoring deuterium exchange after binding of β-chitin, providing direct experimental evidence for binding at this surface for the first time (Aachmann et al., 2012 ▸). A mutagenesis study involving TtAA9_E clearly showed the importance of an aromatic residue in the CBM1-like motif extending from the corresponding putative substrate-binding surface (Harris et al., 2010 ▸), and the distribution of aromatics has been discussed in detail (for example, in Li et al., 2012 ▸). For AA11 the active-site surface is slightly more convex and is devoid of aromatic residues, but has a number of polar residues that are potentially able to make polar interactions with the substrate similarly to AA10 (Hemsworth et al., 2014 ▸). A consensus now exists that many LPMOs interact with their crystalline substrates at relatively flat surfaces, and that binding takes place either through stacking interactions with aromatic residues (e.g. AA9) and/or by polar interactions with hydrophilic residues (e.g. AA10 and AA11).
3.2. Substrate specificity: cellulose, starch and chitin
AA9 was discovered as a family of cellulose-degrading LPMOs, while AA10 was discovered as a chitin-degrading family, although shortly after the discovery of the oxidative degradation of chitin by SmAA10_A the Eijsink group also showed that other AA10 members could degrade cellulose (Forsberg et al., 2011 ▸). As can be seen in the overview of specificities in Table 1 ▸, it still holds that most AA9 family members are cellulose-degrading and AA10 family members degrade chitin or cellulose.
Shortly after the observation of the CBM1-like tyrosines in TtAA9_E (Harris et al., 2010 ▸), the structure of TaAA9_A (Quinlan et al., 2011 ▸) revealed another tyrosine-containing loop on the same surface but on the opposite side with respect to the active site. An equivalent loop and tyrosine were also found in NcAA9_M in a structural study of AA9s from Neurospora crassa (NcAA9_D and NcAA9_M). Here, the loop was denoted L2 (this and other loop positions are marked in Fig. 4 ▸ for LsAA9_A), and it was suggested that the aromatic residues were spatially positioned to accommodate stacking interactions with glucose units within the crystalline cellulose (Li et al., 2012 ▸). In the same publication it was further suggested that an insertion in the cellulose-active ScAA10_C compared with SmAA10_A (extending from a region equivalent to loop L2 in AA9) could account for cellulose specificity. Book et al. (2014 ▸) similarly suggested that this insertion in AA10 members accounted for cellulose specificity and classified this region as motif 1. The Sandgren group showed from MD simulations based on the PcAA9_D structure that the loops L2, LS and LC (the latter harbouring a tyrosine residue which is conserved in most of the structurally characterized AA9 enzymes) had essential roles in interacting with crystalline cellulose (Wu et al., 2013 ▸).
Comparative studies have since been carried out on AA10s active on chitin (SmAA10_A and BlAA10_A) and on cellulose (ScAA10_C and TfAA10_B) (Forsberg, Røhr et al., 2014 ▸). The EPR spectra of the cellulose-active AA10s described were similar to those of the cellulose-active TaAA9_A and distinct from those of chitin-active AA10s. At the same time, it was found that ScAA10_C was able to bind chitin in a nonproductive manner. Based on this, it was proposed that specificity is not defined by the ability of the enzymes to bind substrates, but rather that the copper-centre configuration is a determinant of substrate specificity. As the residues directly involved in copper binding appeared to be identical, it was speculated that positions more remote from the copper were indirectly affecting the active site, causing the differences in substrate specificity. The structures of two cellulose-active AA10s (ScAA10_B and ScAA10_C) were published in the same year (Forsberg, Mackenzie et al., 2014 ▸). Despite the EPR spectra of the two enzymes being similar, the active sites showed clear structural differences, with the active site of ScAA10_C being similar to that of SmAA10_A, while ScAA10_B resembled AA9. Structural comparisons revealed a cavity in the chitin-active AA10 (not found in the cellulose-active AA10s) near the active site, which was proposed to accommodate the N-acetyl group of the substrate (Forsberg, Mackenzie et al., 2014 ▸), but was later shown not to be present in the chitin-active CjAA10_A (Forsberg et al., 2016 ▸). Forsberg, Mackenzie et al. (2014 ▸) also noted that the cellulose-active ScAA10_C had an insertion between strands β6 and β7 (relative to SmAA10_A), positioned spatially equivalent to the LS loop in AA9s, and proposed that substrate specificity was not correlated with the copper centre, but depended on substitutions more remote from the active site affecting substrate interaction. Interestingly, Forsberg et al. (2016 ▸) found that CjAA10_A, as well as lacking the proposed chitin-binding cavity, had an extended flat substrate surface with features of both cellulose-active and chitin-active AA10s, but was only active on chitin. They further made the interesting observation that the catalytic centres of CjAA10_A and AA10s of viral origin are remarkably similar.
With respect to AA11, it is interesting to note that the EPR spectrum of AoAA11 groups together with those of cellulose-active LPMOs (Forsberg, Mackenzie et al., 2014 ▸). Also, considering the L2-equivalent loop (Hemsworth et al., 2014 ▸), that in AoAA11 appears to resemble that of SmAA10_A more than that of ScAA10_C, which is consistent with the experimentally measured chitinolytic activity.
The initial paradigm for LPMOs was that their function is to attack crystalline substrates and favour access by glycoside hydrolases, and as such they possess flat binding sites. Generally speaking, it is said that β-1,4-linked substrates such as cellulose and chitin have a higher tendency to form crystalline structures and thus are harder to access than most starches, which are α-1,4-linked (with additional α-1,6 linkages) and often more digestible, although more recalcitrant forms of starch exist (Pérez & Bertoft, 2010 ▸; Vu & Marletta, 2016 ▸). Starch-active LPMOs (AA13) were first reported in the academic literature by Vu, Beeson, Phillips et al. (2014 ▸). The first (and so far only) available structure of an AA13 is that from Aspergillus oryzae (AoAA13) and was reported by Lo Leggio et al. (2015 ▸). In the AoAA13 structure, no obvious aromatic residues were present at the putative substrate surface. However, this surface appears to be more contoured in AA13s than in other LPMOs that do not act on α-1,4 linkages. In fact, a shallow groove spanning the active site in AoAA13 is likely to play a role in substrate interaction of starch substrates (Fig. 5 ▸), although to date there is no experimental evidence. The groove has a size that fits a single amylose chain, although an amylose double helix has also been proposed to bind (Vu & Marletta, 2016 ▸). Understanding of the AA13 family is lagging behind, but hopefully again the structural studies will guide further biochemical and mutagenesis studies and help us to understand function.
3.3. Regiospecificity
Up to now, we have barely touched on the subject of regiospecificity, namely the preference of LPMOs to oxidize at C1 or C4 or both. In Table 1 ▸, the reported experimental regiospecificity for all structurally characterized LPMOs is given. The first AA10 enzymes to be characterized, for example the chitin-active SmAA10_A (Vaaje-Kolstad et al., 2010 ▸) and the cellulose-active ScAA10_C (Forsberg et al., 2011 ▸), seemed to exclusively oxidize at C1. In contrast, by 2012 AA9s were known to oxidize at C1, C4 or C1/C4, leading to the suggested sequence-based subfamily classification as types 1, 2 or 3, respectively, for the three oxidation modes (Phillips et al., 2011 ▸; Li et al., 2012 ▸; Vu, Beeson, Phillips et al., 2014 ▸). The structures revealed conserved structural features correlating with AA9 C1/C4 regiospecificity such as loop L2 in type 3 LPMOs (Vu, Beeson, Phillips et al., 2014 ▸).
Later, three modular AA9 proteins (AA9-CBM1) from Podospora anserina active on cellulose were characterized (Bennati-Granier et al., 2015 ▸). Of the three proteins, PaAA9_E released C1-oxidized products, while PaAA9_A and PaAA9_H both released C1- and C4-oxidized products. While the sequence and regiospecificity of PaAA9_A and PaAA9_E are in agreement with the previous classification (Vu, Beeson, Phillips et al., 2014 ▸), PaAA9_H was classified on the basis of sequence as a type 2 AA9, which predicts C4 oxidation only, showing that sequence alone may not be sufficient to predict the regiospecificity.
AA10 members generally appear to oxidize mostly at C1, although a double oxidizing ability has been found for some members. To our knowledge, no member of AA10 has been reported to oxidize at C4 alone. The first demonstration of C4 oxidation for an AA10 member was for ScAA10_B, which oxidizes cellulose at C1/C4 (Forsberg, Røhr et al., 2014 ▸). It was also shown that the C1-oxidizing ScAA10_C and the C1/C4-oxidizing ScAA10_B act in synergy on cellulose (PASC), indicating that these enzymes recognize different regions of the substrates (Forsberg, Røhr et al., 2014 ▸). The synergistic effect was correlated to structural variation of the copper active-site surroundings. Of special interest was a conserved alanine in AA10s that was proposed to limit access to the axial position on the copper (Hemsworth, Davies et al., 2013 ▸; Forsberg, Mackenzie et al., 2014 ▸; Forsberg, Røhr et al., 2014 ▸), although it still allows the copper of C1-oxidizing AA10 to bind two water molecules (Gudmundsson et al., 2014 ▸). Structural comparison showed that this alanine was displaced (∼2.5 Å for Cβ in ScAA10_C_relative to ScAA10_B) owing to the neighbouring residues adopting a different conformation. From the structural observations, it was postulated that the ability of copper to bind a ligand in the axial position could be a determinant of C4-oxidizing activity, and that the degree of accessibility to the axial position on the copper determines the regiospecificity of AA10s, simultaneously suggesting that a similar correlation would exist for other families (e.g. for AA9).
When the structure of NcAA9_C was determined (Borisova et al., 2015 ▸), a correlation was indeed found. The authors observed that an Ala or Asp at a position packing against the internal active-site His (as in NcAA9_C and NcAA9_D, respectively) would allow an axial ligand, leading to C4 oxidation, and a partially open axial position (with Pro at this position) would lead to C1/C4 oxidation (as in TaAA9_A), while a Tyr would block the axial position, leading to C1 oxidation (as in PcAA9_D or TtAA9_E). However, it must be noted that for TtAA9_E a slightly distorted axial coordination to the metal (zinc in this case) is possible (see Fig. 4 ▸ c), and in NcAA9_F (a likely C1 oxidizer), which was not included in the Borisova analysis since this structure was published almost at the same time, the axial water is present and in fact interacts with the corresponding Tyr. Thus, the coordination is likely to be affected but not blocked as such. The few characterized members of AA11 and AA13 release C1-oxidized products. No determinants of regiospecificity have yet been proposed, given the lack of experimental evidence.
3.4. Soluble substrates
Initially, several LPMOs had been characterized as acting on insoluble substrates. NcAA9_C was then reported to act on both cellulose and small soluble cellooligosaccharides (Isaksen et al., 2014 ▸). Agger and coworkers later reported NcAA9_C activity on (1→3, 1→4)-β-d-glucan (MLG) and on certain hemicelluloses such as xyloglucans (XG) and to lesser extent glucomannan (Agger et al., 2014 ▸). Similar to NcAA9_C, PaAA9_H (Bennati-Granier et al., 2015 ▸) also showed activity on soluble substrates such as cellooligosaccharides [degree of polymerization (DP) of 4–6] and certain hemicelluloses such as XG, glucomannan, MLG and lichenan. Unfortunately, no structure of PaAA9_H is available.
The structure of NcAA9_C was published by Borisova et al. (2015 ▸), and showed that an insertion, denoted loop L3 (which is absent in AA9s that do not act on soluble substrates, for example TaAA9_A), was involved in forming the substrate-binding surface. Although interaction with substrate was measured with micromolar affinity, no complex structures were obtained. We finally managed to determine a crystallographic complex with an AA9 LPMO from Lentinus similis (LsAA9_A), the first of the kind (Frandsen et al., 2016 ▸). LsAA9_A is also active on cellulose and soluble cellooligosaccharides (>DP2), and the structures revealed several polar residues around the active site interacting with cellotriose (G3) and cellohexaose (G6) at subsites −1 to +2 and −4 to +2, respectively. In this notation, cleavage occurs between subsite −1 and subsite +1, with ‘−’ corresponding to the nonreducing end and ‘+’ corresponding to the reducing end (Davies et al., 1997 ▸), in analogy with GHs. The LsAA9_A–G6 structure revealed that the glucosyl unit at subsite −3 was stacking with the surface-exposed tyrosine (in the LC loop of most AA9s), confirming the involvement of this aromatic residue in substrate interaction. Intriguingly, however, this residue is missing in the cellulose-active NcAA9_F (Tan et al., 2015 ▸), even though it is conserved in all other determined AA9 structures. In addition, in LsAA9_A complexes, the glucosyl unit at subsite +1 stacked directly on top of the methylated His1 (O5 lone pair–aromatic interaction), while several polar residues made hydrogen bonds to the substrate at the rest of the subsites. The terminal glucosyl unit at the reducing end of the substrates was anchored at subsite +2 through hydrogen bonds to Asn28, His66 and Asn67 (Fig. 4 ▸ a).
Both the chair conformations and the glycosidic torsion angles of the complexes in Frandsen et al. (2016 ▸) very closely resemble ideal values, showing that complex formation drives very little distortion of the substrate. This is highly exceptional in enzyme catalysis, as a comparison with the Michaelis–Menten complex of a classic glycoside hydrolase easily illustrates (Fig. 4 ▸ b). Thus, the energy for breaking the glycosidic linkage must fully come from the exceptional chemistry of the copper–oxygen activation. With the first structure of an LPMO–carbohydrate complex structure at almost atomic level resolution combined with spectroscopic methods (EPR), substantial and detailed insights into the mechanism of action of LPMOs were obtained (Frandsen et al., 2016 ▸), which are further elaborated in the next section.
The LsAA9_A complexes also confirmed the involvement of loop L3 in substrate binding, as had been speculated for NcAA9_C (Borisova et al., 2015 ▸), as this loop formed a structural ridge interacting with the glucosyl unit at subsite +2 (Figs. 4 ▸ and 5 ▸), which in fact is also present in NcAA9_D (Li et al., 2012 ▸). It would be interesting to determine whether NcAA9_D might also have activity on cellooligosaccharides, which to our knowledge has not been reported. Shortly after the publication of the LsAA9_A complexes, an NMR study on NcAA9_C showed relatively similar interactions with cellohexaose (G6) and xyloglucans (XG14, polyXG), although G6 did not span as far as the conserved surface Tyr (rather, the data suggested binding from −3 to +3; Courtade et al., 2016 ▸). Interestingly, Courtade and coworkers also showed significant chemical shift differences for certain residues in the L3 loop. In Isaksen et al. (2014 ▸) it was suggested that three conserved Asn residues in NcAA9_C are involved in the binding of cellooligosaccharides. In Courtade et al. (2016 ▸) these residues were not reported to be affected by NMR titration. In LsAA9_A only the central one of these equivalent Asn residues (Asn28) is involved in the binding of G6/G3, while in PaAA9_H they are substituted by Ser25, Asn26 and Phe27, indicating that only the central Asn is involved in the binding of cellooligosaccharides. Lacking structural data, Bennati-Granier et al. (2015 ▸) speculated that loop L3 (in PaAA9H spanning Gly64–Ser83) with the polar residues Glu66, Asp75 and Asp77 (the equivalent residues in NcAA9_C are Glu65, Asp74 and Asp76) was responsible for XG specificity. The interaction of LsAA9_A Asn67 with substrate (equivalent to NcAA9_C Glu65) demonstrates that this residue contributes to the specificity towards substrates with a β-(1,4)-linked glucose backbone rather than solely XG. From structural comparison with LsAA9_A, it would seem that the aspartates could be involved in XG specificity (possibly interacting with substitutions originating from subsites −2 or +3).
3.5. Electron donors/redox partners
In order to catalyse the oxidation of polysaccharides, LPMOs are dependent on redox partners that donate electrons which are used to reduce the active-site copper and to activate molecular oxygen. These electron donors range from small molecules (ascorbate, gallate, reduced glutathione and others) to insoluble lignin polymers and endogenous modular macromolecules (Vaaje-Kolstad et al., 2010 ▸; Phillips et al., 2011 ▸; Langston et al., 2011 ▸; Quinlan et al., 2011 ▸; Dimarogona et al., 2012 ▸). When oxidative activity was first found for SmAA10_A small-molecule electron donors were used, as is frequently performed when testing for LPMO activity. After lignin was identified to function as an electron donor, it was also shown that long-range electron transfer (ET) from lignin to LPMOs can occur (Westereng et al., 2015 ▸). The first evidence for an endogenous redox partner came in 2011, when cellobiose dehydrogenase (CDH) was indicated by in vivo experiments to function as source of electrons for AA9s in T. terrestris and N. crassa, a function which is now well established. Li et al. (2012 ▸) first proposed putative electron pathways based on a conserved patch mapped on the structures, where the haem-containing domain of CDH was docked computationally. At least two potential CDH sites and pathways are reviewed in Beeson et al. (2015 ▸). In AA13 a putative electron-transfer pathway (Tyr224, Trp215, Trp83, Phe95 and Phe161) has also been proposed for AoAA13 (Lo Leggio et al., 2015 ▸). Tan et al. (2015 ▸) suggested direct electron transfer to the LPMO-active site from the haem-containing domain of CDH, and recent NMR spectroscopy studies also showed that CDH appears to interact with NcAA9_C on the flat substrate surface (Courtade et al., 2016 ▸). This finding is intriguing since this would imply competition of CDH and substrate or that all electrons are delivered before the substrate. Recent studies show that light-excited photosynthetic pigments are excellent electron donors and can considerably speed up the LPMO reaction (Cannella et al., 2016 ▸), and a pathway for electron transfer involving His87 of TaAA9_A or a similarly placed residue in other AA9 LPMOs was suggested. Intriguingly, LPMOs are extremely promiscuous when it comes to accepting electrons from CDHs; for example, NcAA13 was able to accept electrons from Myceliophthora thermophila CDH-2 (Vu, Beeson, Phillips et al., 2014 ▸). Recently, it has been shown that other dehydrogenases than CDH can function as redox partners for LPMOs (Kracher et al., 2016 ▸; Garajova et al., 2016 ▸).
3.6. Catalytic mechanisms
The first elucidation of the enzymatic mechanism of LPMOs was achieved in 2010 (Vaaje-Kolstad et al., 2010 ▸), when it was shown using isotope-labelled 18O2 that SmAA10_A incorporates one O atom into the substrate (chitin), establishing LPMOs as monooxygenases. Although the exact catalytic mechanisms of LPMOs are unknown, proposals have been put forward suggesting that LPMOs oxygenate their substrates using activated oxygen species in a putative mechanism involving two electrons. Other naturally occurring, well characterized monooxygenases which accomplish two-electron oxidations of their substrate with mononuclear type 2 copper centres are amine oxidase (AmO; Shepard & Dooley, 2015 ▸), galactose oxidase (GO; Solomon et al., 2001 ▸), peptidylglycine α-hydroxylating monooxygenase (PHM; Solomon et al., 2014 ▸) and dopamine β-monooxygenase (DβM; Klinman, 2006 ▸). In AmO and GO a protein-derived cofactor functioning as a redox-active functional group is formed (in GO a covalent thioether bond is formed between a tyrosine and a cysteine) in an event known as cofactor biogenesis (Shepard & Dooley, 2015 ▸; Solomon et al., 2014 ▸), allowing the enzymes to stabilize radicals forming during catalysis. PHM and DβM contain two mononuclear sites and are also known as noncoupled binuclear copper enzymes. In these enzymes hydroxylation occurs by the first site and another electron is provided using long-range (∼11 Å in PHM) ET from the other site (Solomon et al., 2001 ▸, 2014 ▸; Chen & Solomon, 2004 ▸). In LPMOs no additional redox centres or intramolecular sites for ET have been reported. The ability of LPMOs to catalyse reactions despite lacking the functionalities of other mononuclear monooxygenases (cofactor biogenesis or intramolecular ET sites), combined with their atypical ligand (bidentate coordinated N-terminal histidine), makes them unique in terms of their copper chemistry and explains the attention that they have gained in the field of bioinorganic chemistry. The first LPMO mechanism proposed involved a copper(II)-superoxo species abstracting an H atom from the substrate followed by hydroxylation of either C1 or C4 (Phillips et al., 2011 ▸; Beeson et al., 2012 ▸). In support of this mechanism, in the structures of AA9s from N. crassa (NcAA9_C and NcAA9_M) dioxygen species (superoxide and peroxide) were modelled in elongated electron density by the axial position on the copper (Li et al., 2012 ▸). Later, Kjaergaard et al. (2014 ▸) showed using a spectroscopic and computational study that the unique bidentate N-terminal ligand leads to a T-shaped copper(I) site and is advantageous in strong oxygen binding with minimal reorganization energy. Concurrently, an oxygen-rebound mechanism involving a copper(II)-oxyl species [in equilibrium with copper(III)-OH] was shown from calculations to be energetically more favourable (Kim et al., 2014 ▸). A copper(III) species, although so far mostly proposed for small-molecule model complexes (Donoghue et al., 2011 ▸; Dhar & Tolman, 2015 ▸), has been hypothesized for DβM (Kamachi et al., 2005 ▸; Yoshizawa et al., 2006 ▸; Itoh, 2006 ▸) and also speculated for LPMOs in Quinlan et al. (2011 ▸). Recently, it was suggested that the copper(II)-oxyl ↔ copper(III)-OH tautomerization described by Dhar & Tolman (2015 ▸) and Gagnon & Tolman (2015 ▸) could take place via proton abstraction from the LPMO amino-terminus [H2N-copper(II)-O ↔ HN-copper(III)-OH]. Interestingly, from a structural perspective, the LsAA9_A–copper(II)–G3 (PDB entry 5acf) structure shows a hydrogen-bonding network linking the substrate to the amino-terminus (through a water molecule denoted as the ‘pocket water’), thus supporting this notion. The LsAA9_A–copper(II)–G3 structure in Frandsen et al. (2016 ▸) showed that the binding of a glucosyl unit at subsite +1 placed the C6 close to copper, displacing the axial ligand (Fig. 4 ▸) and inducing a shortening of the Cu–Tyr distance. At the same time, the binding of a heavier chloride ligand at the equatorial position, which could be taken to mimic superoxide, was observed. This species was also clearly visualized by EPR spectroscopy, providing insights into the mode of action of LPMOs. This implies that the ability to coordinate/displace a water molecule in the axial position would be a prerequisite for function and is evidence against the binding of molecular dioxygen in the axial position, as proposed by Li et al. (2012 ▸). Displacement of the axial water when binding the substrate may occur regardless of regiospecifity, although experimental evidence for C1 oxidizers is lacking. In the C1 oxidizers TtAA9_E and NcAA9_F axial ligands to the copper are visible in some of the structures, although limitation of axial access has been proposed as a determinant of regiospecificity (Borisova et al., 2015 ▸). The hydroxyl group of the tyrosine side chains proposed to block the axial water access could instead have a similar function to the ‘pocket water’ in LsAA9_A (see Fig. 4 ▸ c). In this respect, it is also interesting to note that in AoAA13 the backbone carbonyl of a glycine is also spatially positioned similarly to the ‘pocket water’ of LsAA9_A.
In conclusion, the exact mechanism and whether it is exactly preserved in all LPMOs is still uncertain, and several routes regarding the formation of the oxygen species have been proposed and recently reviewed (Beeson et al., 2015 ▸; Walton & Davies, 2016 ▸).
4. A final survey of available structures with a special focus on the last two years
Table 1 ▸ collects information on all LPMO structures determined to date, most of which have already been discussed in some detail in previous sections of this review. As well as their known specificity, the table attempts to collect information of interest to a crystallographer, including the active-site metal modelled and its occupancy, the resolution and the crystallization conditions. Structures are available for 25 individual LPMO family members, including nine AA9s, 14 AA10s, one AA11 and one AA13, with a total of 56 PDB entries. Of the nine individual AA9 members, seven have a copper-loaded structure, of which three are mainly in a copper(II) state, while of the 14 AA10 members nine are available as copper-loaded and two as copper(II), somewhat supporting the suggestion in Hemsworth, Taylor et al. (2013 ▸) that AA10s are easier to photoreduce. The single AA11 and AA13 LPMOs for which a structure is available have a photoreduced copper(I).
The highest resolution record goes to the 0.95 Å resolution structure of EfAA10_A, which is unfortunately devoid of metal in the active site (Vaaje-Kolstad et al., 2012 ▸). The next highest resolution is for NcAA9_D (Li et al., 2012 ▸) and NcAA9_F (Tan et al., 2015 ▸), both of which were determined at 1.10 Å resolution and with copper. It is remarkable, and almost certainly a consequence of the compactness of the structure, that only four of the deposited structures have a resolution worse than 2.00 Å and none have a resolution worse than 2.50 Å. This count includes the structures of fusolin, a spindle-forming virulence factor found in insect viruses, which deserves a special mention in a review aimed at crystallographers, because fusolin is in a crystalline state in its native form and because of the technical achievement in determining the structure from natural crystals (Chiu et al., 2015 ▸). The spindles were harvested from infected insects and larvae and purified by centrifugation with a sucrose gradient. Tiny crystals (typically ∼3 µm in diameter) were subjected to synchrotron diffraction with a microbeam (5–20 µm) after mounting on micromeshes and data were merged from multiple crystals. Apart from the challenges of data collection, the structure was then solved by ab initio molecular replacement in PHENIX (Rosetta_MR; Terwilliger et al., 2012 ▸) with the structure of SmAA10_A as a template, with which it shares only 14% sequence identity. Mature fusolin has a His brace and metal-binding site typical of the AA10 family, but uniquely among LPMOs forms a domain-swapped dimer through a C-terminal extension (Fig. 2 ▸ d). The structure presents a ‘typical’ flat LPMO surface with both polar residues and notably also Trp residues which could participate in chitin binding. However, bidentate coordination from the carboxylic side chain of a Glu from a symmetry-related molecule replaces the waters commonly found as ligands in this position in nonphotoreduced AA10s, and the glutamate side chain occludes the active site. Normally this would be regarded as an ‘accident’ of crystallization, but as this is a natural form of the protein the authors suggested that this is in fact a way in which fusolin is regulated; the LPMO is inactive in the crystalline spindle, but as it is released the active site becomes accessible and it can promote the degradation of chitin-rich matrices and thus promote infectivity. This hypothesis is supported by the fact that mutants of fusolin where the His brace is disrupted lose their biological function, but to our knowledge LPMO activity has not yet been demonstrated.
Very recently, the structure of the smallest LPMO domain structurally characterized to date, that of Jonesia denitrificans AA10_A, was determined (Mekasha et al., 2016 ▸). This LPMO domain is part of a modular natural protein, but the domain in isolation, which is only 15.5 kDa in mass (142 amino-acid residues), is capable of C1 oxidation of both α-chitin and β-chitin. In Figs. 2 ▸(a) and 2 ▸(b), the structures of SmAA10_A and JdAA10_A are shown side by side to highlight the structural elements that are dispensable for substrate binding and catalysis. It is remarkable that such a small polypeptide is able to catalyze the oxidation of a glycosidic bond, and as such it presently represents the minimal structural requirements for a functional LPMO.
5. Perspectives, challenges and final remarks
One question that will strike most structural biologists is why, if the His-brace motif is so simple, is it restricted to the same three-dimensional architecture? In other words, it seems reasonable to expect that we will eventually find LPMOs which are not structurally related overall to known LPMOs, but have the His brace and a similar mechanism. Structural motifs similar to the His brace have already been noted (Phillips et al., 2011 ▸), in particulate methane monooxygenase (Smith et al., 2011 ▸) and the bacterial copper resistance protein CopC (Zhang et al., 2006 ▸). In either case, the relationship to the LPMO mechanism is not fully understood.
This review focuses primarily on the catalytic domains of LPMOs, but LPMOs are frequently modular enzymes with an AA domain at the N-terminus (this is important, since the N-terminus is one of the Cu ligands) and additional domains, which are often CBMs. AA9 LPMOs are associated with the typically cellulose-binding CBM1 in about a third of occurrences (Book et al., 2014 ▸; Lo Leggio et al., 2012 ▸). AA10 enzymes are also often associated with cellulose-binding CBM2 or CBM3 or chitin-binding CBM5 or CBM12, cumulatively in about a third of instances (Book et al., 2014 ▸). AA13 enzymes owe their identification largely to the association with CBM20, a typical starch-binding CBM (Lo Leggio et al., 2015 ▸; Vu, Beeson, Phillips et al., 2014 ▸). Recently, the characterization of a module of unknown function associated with an LPMO from C. japonicus defined a new family of chitin-binding CBMs, CBM73 (Forsberg et al., 2016 ▸). Removal of the CBM5 and CBM73 chitin-binding modules from full-length CjAA10_A caused reduced LPMO activity on α-chitin (Forsberg et al., 2016 ▸). The importance of CBMs for LPMO function was also underlined by a very recent study in which CBMs were deleted, appended or substituted in LPMOs (Crouch et al., 2016 ▸).
With the determination of the first crystalline complex (Frandsen et al., 2016 ▸), and of course building on a large body of biochemical, spectroscopic and structural knowledge contributed by many groups, the initial steps in the mechanism concurrent with and just after binding have been now delineated in detail, for one member of the LPMO family at least! However, a lot of work remains to perform in characterizing the next stages of the reaction to understand exactly the basis for substrate specificity, the oxygen activation by the His brace, the mechanisms of electron delivery and the release of products. In particular the α-1,4-glucan-active AA13 family remains extremely enigmatic: very little is known other than the products generated by a couple of enzymes and a single enzyme structure (Lo Leggio et al., 2015 ▸) which is too different from the AA9 family to easily extend the recently obtained substrate interaction results to it.
Despite the fact that there are many high-resolution structures, there is no ultrahigh-resolution structure of a catalytically competent LMPO which could be used to unambiguously identify H atoms, yet to investigate the catalytic chemistry in detail small-molecule accuracy would be highly desirable. Photoreduction is likely to be problematic, owing to the high doses that will necessarily be involved, so a serial crystallography approach may be beneficial (Stellato et al., 2014 ▸). Recently, good-resolution (2.1 Å) neutron diffraction data have been collected from a JdAA10_A enzyme crystal (Bacik et al., 2015 ▸), which may provide the first high-quality, room-temperature structure of a completely nonphotoreduced LPMO and additional information on hydrogen positions. Full elucidation of the catalytic mechanism and specificity in detail will necessitate further crystallographic studies with later reaction intermediates and soluble ligands. However, since many LPMOs naturally attack insoluble substrates, a full picture will be only obtained by the additional use of other techniques, such as NMR spectroscopy (Aachmann et al., 2012 ▸; Courtade et al., 2016 ▸) and atomic force microscopy (Eibinger et al., 2014 ▸). Transient interactions with natural electron donors may also turn out to be more amenable to NMR spectroscopy (Courtade et al., 2016 ▸) than crystallography, unless the complexes can be stabilized.
In many organisms, there is a tremendous redundancy of LMPOs, in particular in the fungal family AA9. It has been estimated that plant cell wall-degrading fungi have an average of ten AA9 genes (Busk & Lange, 2015 ▸), with some having rather more extreme numbers. We can expect that for AA9 in particular we have as yet to see the full functional and structural diversity, and crystallography will continue to play an important role in this journey of discovery. We have already seen that although initially all LPMOs seemed to be crystalline polysaccharide degraders with flat binding surfaces, we now know that they also can degrade soluble hemicelluloses with a β-1,4-glucan backbone, as does NcAA9_C (Agger et al., 2014 ▸), and there are indications, although no structural characterization, that some members of the family may degrade xylan, alone or when bound to cellulose (Frommhagen et al., 2015 ▸; Kim et al., 2016 ▸). Unusual members of the LPMO family with a missing His brace owing to an N-terminal Arg have been noted in Phanerochaete chrysosporium and Heterobasidion irregulare (Yakovlev et al., 2012 ▸; Wu et al., 2013 ▸). Recently, there has even been a suggestion that AA11 may play an important role in keratin degradation, although this is not likely to be by attacking keratin itself (Lange et al., 2016 ▸).
Aside from the structural questions, there are number of more biological questions about LPMOs, for example their role in the global carbon cycle and their regulation and role in the regulation of biomass degradation in nature, as well as the exciting prospect of fine-tuning them as tools to turn our garbage into convenient energy. Clearly, a fundamental understanding of the reaction has a role to play here, as suggested by a recent report of light activation of LPMOs using photosynthetic pigments such as chlorophyll (Cannella et al., 2016 ▸), with a staggering effect on their activity.
Note added in proof. An additional structure of BaAA10_A has been deposited in the PDB (PDB entry 5iju) after Gregory et al. (2016 ▸).
Acknowledgments
LLL would like to acknowledge her continued collaboration on LPMOs with Novozymes A/S, a major enzyme producer, and the Danish Council for Strategic Research (grant No. 12-134923) for funding KEHF and some of the recent LPMO research through the CESBIC consortium, which also includes the University of Cambridge, the University of York, the CNRS Marseille and Novozymes A/S. Furthermore, the most sincere thanks to Jens-Christian N. Poulsen (University of Copenhagen) for excellent technical assistance and scientific input throughout all of our work with LPMOs, and the ESRF and MAX-lab synchrotrons and their staff for beamtime and assistance during many data collections.
References
- Aachmann, F. L., Sørlie, M., Skjåk-Braek, G., Eijsink, V. G. H. & Vaaje-Kolstad, G. (2012). Proc. Natl Acad. Sci. USA, 109, 18779–18784. [DOI] [PMC free article] [PubMed]
- Agger, J. W., Isaksen, T., Várnai, A., Vidal-Melgosa, S., Willats, W. G., Ludwig, R., Horn, S. J., Eijsink, V. G. H. & Westereng, B. (2014). Proc. Natl Acad. Sci. USA, 111, 6287–6292. [DOI] [PMC free article] [PubMed]
- Bacik, J.-P., Mekasha, S., Forsberg, Z., Kovalevsky, A., Nix, J. C., Cuneo, M. J., Coates, L., Vaaje-Kolstad, G., Chen, J. C.-H., Eijsink, V. G. H. & Unkefer, C. J. (2015). Acta Cryst. F71, 1448–1452. [DOI] [PMC free article] [PubMed]
- Bayer, E. A., Lamed, R. & Himmel, M. E. (2007). Curr. Opin. Biotechnol. 18, 237–245. [DOI] [PubMed]
- Beeson, W. T., Phillips, C. M., Cate, J. H. & Marletta, M. A. (2012). J. Am. Chem. Soc. 134, 890–892. [DOI] [PubMed]
- Beeson, W. T., Vu, V. V., Span, E. A., Phillips, C. M. & Marletta, M. A. (2015). Annu. Rev. Biochem. 84, 923–946. [DOI] [PubMed]
- Béguin, P. (1990). Annu. Rev. Microbiol. 44, 219–248. [DOI] [PubMed]
- Bennati-Granier, C., Garajova, S., Champion, C., Grisel, S., Haon, M., Zhou, S., Fanuel, M., Ropartz, D., Rogniaux, H., Gimbert, I., Record, E. & Berrin, J.-G. (2015). Biotechnol. Biofuels, 8, 90. [DOI] [PMC free article] [PubMed]
- Blake, C. C. F., Koenig, D. F., Mair, G. A., North, A. C. T., Phillips, D. C. & Sarma, V. R. (1965). Nature (London), 206, 757–761. [DOI] [PubMed]
- Book, A. J., Yennamalli, R. M., Takasuka, T. E., Currie, C. R., Phillips, G. N. & Fox, B. G. (2014). Biotechnol. Biofuels, 7, 109. [DOI] [PMC free article] [PubMed]
- Boraston, A. B., Bolam, D. N., Gilbert, H. J. & Davies, G. J. (2004). Biochem. J. 382, 769–781. [DOI] [PMC free article] [PubMed]
- Borisova, A. S., Isaksen, T., Dimarogona, M., Kognole, A. A., Mathiesen, G., Várnai, A., Røhr, Å. K., Payne, C. M., Sørlie, M., Sandgren, M. & Eijsink, V. G. H. (2015). J. Biol. Chem. 290, 22955–22969. [DOI] [PMC free article] [PubMed]
- Bornscheuer, U., Buchholz, K. & Seibel, J. (2014). Angew. Chem. Int. Ed. 53, 10876–10893. [DOI] [PubMed]
- Brown, K., Harris, P., Zaretsky, E., Re, E., Vlasenko, E., Mcfarland, K. & Lopez, D. L. A. (2006). Patent WO2005074647.
- Busk, P. K. & Lange, L. (2015). BMC Genomics, 16, 368. [DOI] [PMC free article] [PubMed]
- Cannella, D., Möllers, K. B., Frigaard, N. U., Jensen, P. E., Bjerrum, M. J., Johansen, K. S. & Felby, C. (2016). Nat. Commun. 7, 11134. [DOI] [PMC free article] [PubMed]
- Carpita, N. C. & Gibeaut, D. M. (1993). Plant J. 3, 1–30. [DOI] [PubMed]
- Chaplin, A. K., Wilson, M. T., Hough, M. A., Svistunenko, D. A., Hemsworth, G. R., Walton, P. H., Vijgenboom, E. & Worrall, J. A. R. (2016). J. Biol. Chem. 291, 12838–12850. [DOI] [PMC free article] [PubMed]
- Chen, P. & Solomon, E. I. (2004). J. Am. Chem. Soc. 126, 4991–5000. [DOI] [PubMed]
- Chiu, E., Hijnen, M., Bunker, R. D., Boudes, M., Rajendran, C., Aizel, K., Oliéric, V., Schulze-Briese, C., Mitsuhashi, W., Young, V., Ward, V. K., Bergoin, M., Metcalf, P. & Coulibaly, F. (2015). Proc. Natl Acad. Sci. USA, 112, 3973–3978. [DOI] [PMC free article] [PubMed]
- Courtade, G., Wimmer, R., Røhr, A. K., Preims, M., Felice, A. K. G., Dimarogona, M., Vaaje-Kolstad, G., Sørlie, M., Sandgren, M., Ludwig, R., Eijsink, V. G. H. & Aachmann, F. L. (2016). Proc. Natl Acad. Sci. USA, 113, 5922–5927. [DOI] [PMC free article] [PubMed]
- Cragg, S. M., Beckham, G. T., Bruce, N. C., Bugg, T. D. H., Distel, D. L., Dupree, P., Etxabe, A. G., Goodell, B. S., Jellison, J., McGeehan, J. E., McQueen-Mason, S. J., Schnorr, K., Walton, P. H., Watts, J. E. M. & Zimmer, M. (2015). Curr. Opin. Chem. Biol. 29, 108–119. [DOI] [PMC free article] [PubMed]
- Crichton, R. R. (2012). Biological Inorganic Chemistry: A New Introduction to Molecular Structure and Function, 2nd ed. Amsterdam: Elsevier.
- Crouch, L. I., Labourel, A., Walton, P. H., Davies, G. J. & Gilbert, H. J. (2016). J. Biol. Chem. 291, 7439–7449. [DOI] [PMC free article] [PubMed]
- Davies, G. J., Mackenzie, L., Varrot, A., Dauter, M., Brzozowski, A. M., Schülein, M. & Withers, S. G. (1998). Biochemistry, 37, 11707–11713. [DOI] [PubMed]
- Davies, G. J., Wilson, K. S. & Henrissat, B. (1997). Biochem. J. 321, 557–559. [DOI] [PMC free article] [PubMed]
- Dhar, D. & Tolman, W. B. (2015). J. Am. Chem. Soc. 137, 1322–1329. [DOI] [PMC free article] [PubMed]
- Dimarogona, M., Topakas, E., Olsson, L. & Christakopoulos, P. (2012). Bioresour. Technol. 110, 480–487. [DOI] [PubMed]
- Doan, N. & Gettins, P. W. (2007). Biochem. J. 407, 23–30. [DOI] [PMC free article] [PubMed]
- Donoghue, P. J., Tehranchi, J., Cramer, C. J., Sarangi, R., Solomon, E. I. & Tolman, W. B. (2011). J. Am. Chem. Soc. 133, 17602–17605. [DOI] [PMC free article] [PubMed]
- Eibinger, M., Ganner, T., Bubner, P., Rošker, S., Kracher, D., Haltrich, D., Ludwig, R., Plank, H. & Nidetzky, B. (2014). J. Biol. Chem. 289, 35929–35938. [DOI] [PMC free article] [PubMed]
- Eriksson, K.-E., Pettersson, B. & Westermark, U. (1974). FEBS Lett. 49, 282–285. [DOI] [PubMed]
- Fleming, A. (1922). Proc. R. Soc. B: Biol. Sci. 93, 306–317.
- Floudas, D. et al. (2012). Science, 336, 1715–1719. [DOI] [PubMed]
- Floudas, D. et al. (2015). Fungal Genet. Biol. 76, 78–92. [DOI] [PMC free article] [PubMed]
- Forsberg, Z., Mackenzie, A. K., Sørlie, M., Røhr, Å. K., Helland, R., Arvai, A. S., Vaaje-Kolstad, G. & Eijsink, V. G. H. (2014). Proc. Natl Acad. Sci. USA, 111, 8446–8451. [DOI] [PMC free article] [PubMed]
- Forsberg, Z., Nelson, C. E., Dalhus, B., Mekasha, S., Loose, J. S. M., Crouch, L. I., Røhr, A. K., Gardner, J. G., Eijsink, V. G. H. & Vaaje-Kolstad, G. (2016). J. Biol. Chem. 291, 7300–7312. [DOI] [PMC free article] [PubMed]
- Forsberg, Z., Røhr, Å. K., Mekasha, S., Andersson, K. K., Eijsink, V. G. H., Vaaje-Kolstad, G. & Sørlie, M. (2014). Biochemistry, 53, 1647–1656. [DOI] [PubMed]
- Forsberg, Z., Vaaje-Kolstad, G., Westereng, B., Bunaes, A. C., Stenstrøm, Y., MacKenzie, A., Sørlie, M., Horn, S. J. & Eijsink, V. G. H. (2011). Protein Sci. 20, 1479–1483. [DOI] [PMC free article] [PubMed]
- Frandsen, K. E. et al. (2016). Nat. Chem. Biol. 12, 298–303. [DOI] [PMC free article] [PubMed]
- Frederiksen, R. F., Paspaliari, D. K., Larsen, T., Storgaard, B. G., Larsen, M. H., Ingmer, H., Palcic, M. M. & Leisner, J. J. (2013). Microbiology, 159, 833–847. [DOI] [PubMed]
- Frommhagen, M., Sforza, S., Westphal, A. H., Visser, J., Hinz, S. W. A., Koetsier, M. J., van Berkel, W. J. H., Gruppen, H. & Kabel, M. A. (2015). Biotechnol. Biofuels, 8, 101. [DOI] [PMC free article] [PubMed]
- Fuchs, R. L., McPherson, S. A. & Drahos, D. J. (1986). Appl. Environ. Microbiol. 51, 504–509. [DOI] [PMC free article] [PubMed]
- Gagnon, N. & Tolman, W. B. (2015). Acc. Chem. Res. 48, 2126–2131. [DOI] [PMC free article] [PubMed]
- Garajova, S., Mathieu, Y., Beccia, M. R., Bennati-Granier, C., Biaso, F., Fanuel, M., Ropartz, D., Guigliarelli, B., Record, E., Rogniaux, H., Henrissat, B. & Berrin, J.-G. (2016). Sci. Rep. 6, 28276. [DOI] [PMC free article] [PubMed]
- Gibson, D. M., King, B. C., Hayes, M. L. & Bergstrom, G. C. (2011). Curr. Opin. Microbiol. 14, 264–270. [DOI] [PubMed]
- Glass, N. L., Schmoll, M., Cate, J. H. D. & Coradetti, S. (2013). Annu. Rev. Microbiol. 67, 477–498. [DOI] [PubMed]
- Gregory, R. C., Hemsworth, G. R., Turkenburg, J. P., Hart, S. J., Walton, P. H. & Davies, G. J. (2016). Dalton Trans. 10.1039/c6dt02793h. [DOI] [PubMed]
- Gudmundsson, M., Kim, S., Wu, M., Ishida, T., Momeni, M. H., Vaaje-Kolstad, G., Lundberg, D., Royant, A., Stahlberg, J., Eijsink, V. G. H., Beckham, G. T. & Sandgren, M. (2014). J. Biol. Chem. 289, 18782–18792. [DOI] [PMC free article] [PubMed]
- Guerriero, G., Hausman, J. F., Strauss, J., Ertan, H. & Siddiqui, K. S. (2016). Eng. Life Sci. 16, 1–16.
- Harris, P. V., Welner, D., McFarland, K. C., Re, E., Navarro Poulsen, J. C., Brown, K., Salbo, R., Ding, H., Vlasenko, E., Merino, S., Xu, F., Cherry, J., Larsen, S. & Lo Leggio, L. (2010). Biochemistry, 49, 3305–3316. [DOI] [PubMed]
- Harris, P. V., Xu, F., Kreel, N. E., Kang, C. & Fukuyama, S. (2014). Curr. Opin. Chem. Biol. 19, 162–170. [DOI] [PubMed]
- Hayes, M., Carney, B., Slater, J. & Brück, W. (2008). Biotechnol. J. 3, 878–889. [DOI] [PubMed]
- Hellemond, E. W. van, Leferink, N. G. H., Heuts, D., Fraaije, M. W. & van Berkel, W. J. H. (2006). Adv. Appl. Microbiol., 60, 17–54. [DOI] [PubMed]
- Hemsworth, G. R., Davies, G. J. & Walton, P. H. (2013). Curr. Opin. Struct. Biol. 23, 660–668. [DOI] [PubMed]
- Hemsworth, G. R., Henrissat, B., Davies, G. J. & Walton, P. H. (2014). Nat. Chem. Biol. 10, 122–126. [DOI] [PMC free article] [PubMed]
- Hemsworth, G. R., Johnston, E. M., Davies, G. J. & Walton, P. H. (2015). Trends Biotechnol. 33, 747–761. [DOI] [PubMed]
- Hemsworth, G. R., Taylor, E. J., Kim, R. Q., Gregory, R. C., Lewis, S. J., Turkenburg, J. P., Parkin, A., Davies, G. J. & Walton, P. H. (2013). J. Am. Chem. Soc. 135, 6069–6077. [DOI] [PMC free article] [PubMed]
- Henrissat, B. (1991). Biochem. J. 280, 309–316. [DOI] [PMC free article] [PubMed]
- Henrissat, B., Claeyssens, M., Tomme, P., Lemesle, L. & Mornon, J.-P. (1989). Gene, 81, 83–95. [DOI] [PubMed]
- Henrissat, B. & Davies, G. (1997). Curr. Opin. Struct. Biol. 7, 637–644. [DOI] [PubMed]
- Holm, L., Kääriäinen, S., Rosenström, P. & Schenkel, A. (2008). Bioinformatics, 24, 2780–2781. [DOI] [PMC free article] [PubMed]
- Horn, S. J., Vaaje-Kolstad, G., Westereng, B. & Eijsink, V. G. H. (2012). Biotechnol. Biofuels, 5, 45. [DOI] [PMC free article] [PubMed]
- Isaksen, T., Westereng, B., Aachmann, F. L., Agger, J. W., Kracher, D., Kittl, R., Ludwig, R., Haltrich, D., Eijsink, V. G. H. & Horn, S. J. (2014). J. Biol. Chem. 289, 2632–2642. [DOI] [PMC free article] [PubMed]
- Itoh, S. (2006). Curr. Opin. Chem. Biol. 10, 115–122. [DOI] [PubMed]
- Itzstein, M. von & Thomson, R. (2009). Antiviral Strategies, edited by H.-G. Krausslich & R. Bartenschlager, pp. 111–154. Berlin, Heidelberg: Springer-Verlag.
- Johansen, K. S. (2016a). Biochem. Soc. Trans. 44, 143–149. [DOI] [PubMed]
- Johansen, K. S. (2016b). Trends Plant Sci., 10.1016/j.tplants.2016.07.012.
- Kamachi, T., Kihara, N., Shiota, Y. & Yoshizawa, K. (2005). Inorg. Chem. 44, 4226–4236. [DOI] [PubMed]
- Karkehabadi, S., Hansson, H., Kim, S., Piens, K., Mitchinson, C. & Sandgren, M. (2008). J. Mol. Biol. 383, 144–154. [DOI] [PubMed]
- Karlsson, J., Saloheimo, M., Siika-Aho, M., Tenkanen, M., Penttilä, M. & Tjerneld, F. (2001). Eur. J. Biochem. 268, 6498–6507. [DOI] [PubMed]
- Kim, S., Ståhlberg, J., Sandgren, M., Paton, R. S. & Beckham, G. T. (2014). Proc. Natl Acad. Sci. USA, 111, 149–154. [DOI] [PMC free article] [PubMed]
- Kim, I. J., Youn, H. J. & Kim, K. H. (2016). Process Biochem., 10.1016/j.procbio.2016.06.017.
- Kjaergaard, C. H., Qayyum, M. F., Wong, S. D., Xu, F., Hemsworth, G. R., Walton, D. J., Young, N. A., Davies, G. J., Walton, P. H., Johansen, K. S., Hodgson, K. O., Hedman, B. & Solomon, E. I. (2014). Proc. Natl Acad. Sci. USA, 111, 8797–8802. [DOI] [PMC free article] [PubMed]
- Klinman, J. P. (2006). J. Biol. Chem. 281, 3013–3016. [DOI] [PubMed]
- Kohler, A. et al. (2015). Nat. Genet. 47, 410–415. [DOI] [PubMed]
- Kracher, D., Scheiblbrandner, S., Felice, A. K. G., Breslmayr, E., Preims, M., Ludwicka, K., Haltrich, D., Eijsink, V. G. H. & Ludwig, R. (2016). Science, 352, 1098–1101. [DOI] [PubMed]
- Lange, L., Huang, Y. H. & Busk, P. K. (2016). Appl. Microbiol. Biotechnol. 100, 2083–2096. [DOI] [PMC free article] [PubMed]
- Langston, J. A., Shaghasi, T., Abbate, E., Xu, F., Vlasenko, E. & Sweeney, M. D. (2011). Appl. Environ. Microbiol. 77, 7007–7015. [DOI] [PMC free article] [PubMed]
- Levasseur, A., Drula, E., Lombard, V., Coutinho, P. M. & Henrissat, B. (2013). Biotechnol. Biofuels, 6, 41. [DOI] [PMC free article] [PubMed]
- Li, X., Beeson, W. T. IV, Phillips, C. M., Marletta, M. A. & Cate, J. H. D. (2012). Structure, 20, 1051–1061. [DOI] [PMC free article] [PubMed]
- Lo Leggio, L. et al. (2015). Nat. Commun. 6, 5961. [DOI] [PMC free article] [PubMed]
- Lo Leggio, L., Welner, D. & De Maria, L. (2012). Comput. Struct. Biotechnol. J. 2, e201209019. [DOI] [PMC free article] [PubMed]
- Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M. & Henrissat, B. (2014). Nucleic Acids Res. 42, D490–D495. [DOI] [PMC free article] [PubMed]
- Loose, J. S. M., Forsberg, Z., Fraaije, M. W., Eijsink, V. G. H. & Vaaje-Kolstad, G. (2014). FEBS Lett. 588, 3435–3440. [DOI] [PubMed]
- Mekasha, S., Forsberg, Z., Dalhus, B., Bacik, J.-P., Choudhary, S., Schmidt-Dannert, C., Vaaje-Kolstad, G. & Eijsink, V. G. H. (2016). FEBS Lett. 590, 34–42. [DOI] [PubMed]
- Paspaliari, D. K., Loose, J. S. M., Larsen, M. H. & Vaaje-Kolstad, G. (2015). FEBS J. 282, 921–936. [DOI] [PubMed]
- Pérez, S. & Bertoft, E. (2010). Starch, 62, 389–420.
- Phillips, C. M., Beeson, W. T., Cate, J. H. & Marletta, M. A. (2011). ACS Chem. Biol. 6, 1399–1406. [DOI] [PubMed]
- Pollegioni, L., Tonin, F. & Rosini, E. (2015). FEBS J. 282, 1190–1213. [DOI] [PubMed]
- Quinlan, R. J. et al. (2011). Proc. Natl Acad. Sci. USA, 108, 15079–15084.
- Rytioja, J., Hildén, K., Yuzon, J., Hatakka, A., de Vries, R. P. & Mäkelä, M. R. (2014). Microbiol. Mol. Biol. Rev. 78, 614–649. [DOI] [PMC free article] [PubMed]
- Shah, F. et al. (2016). New Phytol. 209, 1705–1719. [DOI] [PMC free article] [PubMed]
- Shepard, E. M. & Dooley, D. M. (2015). Acc. Chem. Res. 48, 1218–1226. [DOI] [PubMed]
- Smith, S. M., Rawat, S., Telser, J., Hoffman, B. M., Stemmler, T. L. & Rosenzweig, A. C. (2011). Biochemistry, 50, 10231–10240. [DOI] [PMC free article] [PubMed]
- Solomon, E. I., Chen, P., Metz, M., Lee, S. K. & Palmer, A. E. (2001). Angew. Chem. Int. Ed. 40, 4570–4590. [DOI] [PubMed]
- Solomon, E. I., Heppner, D. E., Johnston, E. M., Ginsbach, J. W., Cirera, J., Qayyum, M., Kieber-Emmons, M. T., Kjaergaard, C. H., Hadt, R. G. & Tian, L. (2014). Chem. Rev. 114, 3659–3853. [DOI] [PMC free article] [PubMed]
- Span, E. A. & Marletta, M. A. (2015). Curr. Opin. Struct. Biol. 35, 93–99. [DOI] [PubMed]
- Stellato, F. et al. (2014). IUCrJ, 1, 204–212. [DOI] [PMC free article] [PubMed]
- Suzuki, K., Suzuki, M., Taiyoji, M., Nikaidou, N. & Watanabe, T. (1998). Biosci. Biotechnol. Biochem. 62, 128–135. [DOI] [PubMed]
- Tan, T. C., Kracher, D., Gandini, R., Sygmund, C., Kittl, R., Haltrich, D., Hällberg, B. M., Ludwig, R. & Divne, C. (2015). Nat. Commun. 6, 7542. [DOI] [PMC free article] [PubMed]
- Terwilliger, T. C., DiMaio, F., Read, R. J., Baker, D., Bunkóczi, G., Adams, P. D., Grosse-Kunstleve, R. W., Afonine, P. V. & Echols, N. (2012). J. Struct. Funct. Genomics, 13, 81–90. [DOI] [PMC free article] [PubMed]
- Vaaje-Kolstad, G., Bøhle, L. A., Gåseidnes, S., Dalhus, B., Bjørås, M., Mathiesen, G. & Eijsink, V. G. H. (2012). J. Mol. Biol. 416, 239–254. [DOI] [PubMed]
- Vaaje-Kolstad, G., Horn, S. J., Sørlie, M. & Eijsink, V. G. H. (2013). FEBS J. 280, 3028–3049. [DOI] [PubMed]
- Vaaje-Kolstad, G., Horn, S. J., van Aalten, D. M. F., Synstad, B. & Eijsink, V. G. H. (2005). J. Biol. Chem. 280, 28492–28497. [DOI] [PubMed]
- Vaaje-Kolstad, G., Houston, D. R., Riemen, A. H. K., Eijsink, V. G. H. & van Aalten, D. M. F. (2005). J. Biol. Chem. 280, 11313–11319. [DOI] [PubMed]
- Vaaje-Kolstad, G., Westereng, B., Horn, S. J., Liu, Z., Zhai, H., Sørlie, M. & Eijsink, V. G. H. (2010). Science, 330, 219–222. [DOI] [PubMed]
- Vu, V. V., Beeson, W. T., Phillips, C. M., Cate, J. H. D. & Marletta, M. A. (2014). J. Am. Chem. Soc. 136, 562–565. [DOI] [PubMed]
- Vu, V. V., Beeson, W. T., Span, E. A., Farquhar, E. R. & Marletta, M. A. (2014). Proc. Natl Acad. Sci. USA, 111, 13822–13827. [DOI] [PMC free article] [PubMed]
- Vu, V. V. & Marletta, M. A. (2016). Cell. Mol. Life Sci. 73, 2809–2919. [DOI] [PMC free article] [PubMed]
- Walton, P. H. & Davies, G. J. (2016). Curr. Opin. Chem. Biol. 31, 195–207. [DOI] [PubMed]
- Wei, N., Quarterman, J. & Jin, Y.-S. (2013). Trends Biotechnol. 31, 70–77. [DOI] [PubMed]
- Welner, D. H., Jensen, M. H., McFarland, K. C., Poulsen, J.-C. N., Otten, H., Salbo, R., Christensen, U., Harris, P. V., Larsen, S. & Borchert, T. (2009). In Biotechnology of Lignocellulose Degradation and Biomass Utilization – Mie Bioforum 2008. Tokyo: Ito Print Publishing Division.
- Westereng, B., Cannella, D., Agger, J. W., Jørgensen, H., Andersen, M. L., Eijsink, V. G. H. & Felby, C. (2015). Sci. Rep. 5, 18561. [DOI] [PMC free article] [PubMed]
- Westereng, B., Ishida, T., Vaaje-Kolstad, G., Wu, M., Eijsink, V. G. H., Igarashi, K., Samejima, M., Ståhlberg, J., Horn, S. J. & Sandgren, M. (2011). PLoS One, 6, e27807. [DOI] [PMC free article] [PubMed]
- Wong, E., Vaaje-Kolstad, G., Ghosh, A., Hurtado-Guerrero, R., Konarev, P. V., Ibrahim, A. F. M., Svergun, D. I., Eijsink, V. G. H., Chatterjee, N. S. & van Aalten, D. M. F. (2012). PLoS Pathog. 8, e1002373. [DOI] [PMC free article] [PubMed]
- Wu, M., Beckham, G. T., Larsson, A. M., Ishida, T., Kim, S., Payne, C. M., Himmel, M. E., Crowley, M. F., Horn, S. J., Westereng, B., Igarashi, K., Samejima, M., Ståhlberg, J., Eijsink, V. G. H. & Sandgren, M. (2013). J. Biol. Chem. 288, 12828–12839. [DOI] [PMC free article] [PubMed]
- Yakovlev, I., Vaaje-Kolstad, G., Hietala, A. M., Stefańczyk, E., Solheim, H. & Fossdal, C. G. (2012). Appl. Microbiol. Biotechnol. 95, 979–990. [DOI] [PMC free article] [PubMed]
- Yoder, M. D., Keen, N. T. & Jurnak, F. (1993). Science, 260, 1503–1507. [DOI] [PubMed]
- Yoshizawa, K., Kihara, N., Kamachi, T. & Shiota, Y. (2006). Inorg. Chem. 45, 3034–3041. [DOI] [PubMed]
- Zeng, Y., Zhao, S., Yang, S. & Ding, S.-Y. (2014). Curr. Opin. Biotechnol. 27, 38–45. [DOI] [PubMed]
- Zhang, L., Koay, M., Maher, M. J., Xiao, Z. & Wedd, A. G. (2006). J. Am. Chem. Soc. 128, 5834–5850. [DOI] [PubMed]
- Zheng, H., Chordia, M. D., Cooper, D. R., Chruszcz, M., Müller, P., Sheldrick, G. M. & Minor, W. (2014). Nat. Protoc. 9, 156–170. [DOI] [PMC free article] [PubMed]